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ABSTRACT OF THE DISSERTATION
APPLICATIONS OF PAPER MICROFLUIDIC SYSTEMS
IN THE FIELD DETECTION OF DRUGS OF ABUSE
by
Ling Wang
Florida International University, 2017
Miami, Florida
Professor Bruce McCord, Major Professor
Over the years, colorimetric reagents and immunology have been widely used in
screening tests for illicit drugs; however, the test kits are not always convenient
for field use and often require the user to mix and develop a specific set of
reagents. In our project, we have been working on alternative platforms based on
paper microfluidic devices (uPADs) for field testing. These devices utilize wax
channels printed on paper to direct the analyte towards a specific set of chemical
reagents. Using the procedure, we have developed a six-channel chip that
adapts known colorimetric reagents targeting cocaine, opiates, amphetamines
and ketamine for multiplex detection. For more sensitive and specific
determinations than the colorimetric reagents, we have also developed a paper
device that utilizes the interaction between gold nanoparticles and drug specific
aptamers.
The µPADs using colorimetric reagent are designed as a six-channel multiplexed
system. Sequences of different reagents applied to each channel to produce a
series of reactions and the color changes appear at the end of each

v

channel. The entire process takes less than five minutes. The adjusted reagents
produce specific color changes for seized drugs on the paper microfluidic
devices. Procedures have been developed for the detection of cocaine,
ketamine, codeine, ephedrine, morphine, amphetamine, methamphetamine, and
MDMA. These devices have been tested for sensitivity, specificity and stability
against a variety of potential interferences and test conditions.
Gold nanoparticles (AuNPs)/ aptamers µPADs were developed to detect cocaine.
The presence of cocaine cause the binding with aptamers, and the gold
nanoparitcles produced a salt-indicated aggregations and gave a color change of
AuNPs from red to black. The absence of cocaine allowed the aptamers freely to
bind gold nanoparticles, and no color change occured. The device had a
preliminary validation of sensitvity and specificity against a variety of potential
interferences.
The use of paper microfluidic devices permits the development of rapid,
inexpensive and easily operated tests for drug samples in the field. They present
a safe and convenient presumptive tool that can be used in the field.
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Chapter 1. Short History of Drugs of Abuse and Analysis
1. Introduction
Drug abuse has been a global problem for many years. The World Drug
Report has estimated that up to 250 million people used illicit drugs in
2010. [1] In 2014, the report estimated that one in 20 adult individuals
were drug users ,and over 29 million drug abusers suffered disorders such
as HIV and hepatitis; however, only 4.83 million drug addicts with these
issues were in treatment. [2] Drug users have higher risks of health
problems than other non-drug users [3], and are often involved in
antisocial behavior. Almost one in five sentenced prisoners are involved in
a drug-related offense, and the estimated global drug-related deaths was
207,400 per year. [4] In the United States, abuse of illicit and prescription
drugs cost millions of dollars in crime, health and productivity. [5]
The term ‘drug of abuse’ does not have the same meaning as the term
‘illicit drug’ despite the fact they are often mixed in daily life. [6]

For

example, alcohol and tobacco are commonly abused drugs but are legal.
[6] Patterns of drug abuse change with the time and country. Even in the
same country, there exists a diversity of drug consumption depending on
the period, local government and financial status. [4, 6] For example, in
Southeast Asia there is a higher consumption of ketamine than in
northern Europe [7], while North America and Western Europe have a
greater consumption of cannabis than other regions. In South America,
increasing abuse of cocaine has become a great problem. [4]
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Drug control programs have been established for many years. Since the
1980s, the U.S. government has yearly spent billions of dollars in an
attempt to control the illicit drug market; however, the results are limited.
[8] There is a continuing development of new drug analogs along with an
increasing use of mixtures of synthetic and traditional drugs. The
increasing availability of dangerous drugs creates problems in legislation,
control, interdiction, and forensic analysis.

a. Overview of SAMHSA 5
There are an overwhelming number of drugs of abuse, therefore in our
research project, we have focused on a list of important compounds
promulgated by the National Institute on Drug Abuse (SAMHSA-5). The
SAMHSA-5 does not cover the entire set of drugs of abuse, such as new
“designer drugs”, legitimate drugs, or other less prevalent illicit drugs. [9]
The primary concern is to control amphetamines (amphetamine and
methamphetamine), cocaine, marijuana, opiates (codeine, morphine,
heroin) and phencyclidine (PCP). These compounds are commonly
detected as part of a standard five-drug panel.

(1) Cocaine
Cocaine (methylbenzoylecgonine) is an alkaloid which consists an ester of
benzoic acid combined with an amino alcohol methylecgonine. Cocaine
hydrochloride is a white crystalline salt and it can precipitate to yield
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cocaine free base when mixed with potassium permanganate and
aqueous ammonia. [9] Cocaine can be prepared as either the purified
product from the coca paste or a synthesized product from ecgonine via
the Mannich reaction. [9,10]
Cocaine has been used as a topical local anesthetic in medicine. Its mode
of action is to block sodium channels in the central nervous system and
increase the threshold required to generate an action potential. [10]
Acute abuse of cocaine can cause cocaine intoxication, in which
excessive stimulation occurs in the central nervous system. Chironic
usage can cause psychological dependence.
The routes of administration of cocaine are via intravenous (IV), intranasal
(IN), oral (PO) or smoking (SM). Comparing the drug bioavailability, the
oral route has the lowest bioavailability (20%), the IN route is dose
dependent with an estimated range of 25-94%, the SM route has a range
of 57-70%, and the IV route has 100% drug bioavailability. [10] Cocaine
and its metabolites can stay in urine or blood for up to 10 days. [9,10] The
primary metabolites of cocaine are benzoylecgonine and ecogonine
methyl ester. Cutoff concentrations of cocaine and its metabolites are
150ng/mL in screening tests and 100 ng/mL in confirmatory tests. [11]

3

CH3
N
COOCH3

OCOC6H5
H

Cocaine
Chemical hydrolysis,
Liver methylesterase

Plasma pseudocholinesterase,
Liver benzoylesterase
CH3

CH3

N

N
COOCH3

COOH

OH

OCOC6H5

H

H

Benzoylecgonine

Ecgonine methyl ester

Figure 1.1. Main pathways in the primary metabolism of cocaine.

(2) Amphetamines
Amphetamines are central nervous system (CNS) stimulants that mimic
natural hormones. Amphetamine and methamphetamine belong to the
phenethylamine group, and are classified as Schedule II controlled
substances. [9,10] Amphetamines can increase dopamine concentration
at nerve endings and stimulate the CNS. Methamphetamine has a better
CNS efficacy than amphetamine because the extra methyl group
increases its lipophilicity and entry into the CNS. (Figure 1.2) In the urine
samples, up to 45% of methamphetamine and 4-7% of amphetamine are
excreted as the unchanged parent drugs in a 24-hour period. [9] For
detection, the analytical cutoff is 500 ng/mL in screening tests and 250
ng/mL in confirmation tests. [11]
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CH3
H2
C

C
H

CH3

H

H2
C

N
CH3

C

NH2

H

Amphetamine

Methamphetamine

CH3
H2
C

O

C
H

H
N
CH3

O

MDMA

Figure 1.2. Structures of commonly abused phenethyl amines:
methamphetamine, amphetamine, and 3,4-methylenedioxyamphetamine
(MDMA).
3,4-methylenedioxyamphetamine (MDMA) is a designer drug of the
phenethylamine class. It was previously used in therapeutic treatment,
however today it is classed as a Schedule I controlled substance with no
approved medical use. MDMA has a similar sympathomimtic activity to
amphetamine, but its overdose can affect multiple organ systems. [10]
MDMA has a cutoff level of 500 ng/mL in screening tests and 250 ng/mL in
confirmation tests. [11]

(3) Phencyclidines
Phencyclidines(PCPs) are hallucinogens which interact with
neurotransmitter systems and dopaminergic systems. Ketamine is an
analog of PCP and its chemical structure is shown in Figure 1.3. Its salt
form is ketamine hydrochloride and this form is used in medicines.
Ketamine is structurally and pharmacologically related to PCP. It is
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classified as a Schedule III controlled substance because it can be used
as a drug for sexual assault because of its hallucinogenic properties.
Phencyclidine has a cutoff of 25 ng/mL in screening tests and 25 ng/mL in
confirmation tests. [11]
O

N

NHCH3
Cl

Ketamine

PCP

Figure 1.3. Structure of PCP and Ketamine.

(4) Cannabinoids
Cannabinoids are psychoactive products extracted from the Cannabis
sativa plant complex. The products can come from whole plants or finely
chopped leaves and buds. D9-Tetrahydrocannabinol (THC) is the main
component of cannabis, and it has a low toxicity, however, chronic usage
can cause damage to the liver and other organs and impairment of
attention and memory. [9,10] The main metabolite of THC is 11-nor-delta
9- tetrahydrocannabinol carboxylic acid (THC-COOH) which can be found
in blood, urine, hair, sweat, and oral fluids. (Figure 1.4) The drug is usually
detectable from one to 10 days depending on the type of biological
sample. [10] Marijuana metabolites have a 50 ng/mL cutoff in screening
tests and a 15 ng/mL cutoff in confirmation tests. [11]
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The basic structure of opioids contains an aromatic core along with basic
COOH

moieties. Codeine and morphine have a similar structure, and they are
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Schedule II controlled
substances. (Figure 1.5) Both are extracted from
H3C

the opium poppy as opiate alkaloids and are classified as phenanthrenes.
H3C

O

CH3

Opioids have major pharmacologic effects on the CNS because they have
selective binding sites at several receptors. Codeine is a weak µ and κ
agonist, while morphine is a strong µ agonist and a weak κ and δ agonist.
They both can block the transmission of painful stimuli. [10]

H 3C
H 3C
N
N

O-dealkylation

O
HO

O
H3CO

OH

OH

Codeine

Morphine

Figure 1.5. Structures and Metabolism of codeine to morphine.
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CH3

The primarily metabolites of morphine are morphine-3-glucuronide (M3G)
and morphine-6-glucuronide(M6G). Codeine converses to morphine in the
liver via cytochrome P450 enzyme CYP2D6. [10] Approximately 10-20%
of unchanged codeine is excreted in the urine in one day.[9] The
analytical cutoffs for presumptive and confirmatory testing are 2000
ng/mL. [11]

b. Forensic Applications of Drugs Analysis
Typically, there are two steps involved in forensic drug analysis,
presumptive and confirmatory testing. [14] A presumptive test is used to
quickly identify the presence of a drug substance while a confirmatory test
is used to identify and quantify the presence of a target drug. In general, a
presumptive test is less specific and mainly detects drug classes while a
confirmatory test utilizes spectroscopic and chromatographic methods for
a compound specific determination. These tests are described and
standardized by an official organization known as the ‘Scientific Working
Group for the Analysis of seized Drugs’ (SWGDRUG). The SWGDRUG
has published a list of recommendations to assist forensic analysts with
analytical techniques, protocols and policies. The most recent version of
these guidelines was updated in June 2016 as Version 7.1. [15] These
recommendations cover the practices of sampling, drug identification,
validation, quality assurance and education. In this recommendation,
analytical techniques are classified into three types. Category A includes
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infrared spectroscopy (IR), mass spectrometry (MS), nuclear magnetic
resonance spectroscopy (NMR), Raman spectroscopy and X-ray
diffractometry; Category B includes capillary electrophoresis (CE), gas
chromatography (GC), ion mobility spectrometry (IMS), liquid
chromatography (LC), microcrystalline tests, pharmaceutical identifiers,
thin layer chromatography (TLC) and macroscopic/microscopic
examination (only for cannabis); Category C includes color tests,
fluorescence spectroscopy, immunoassays, melting point, and ultraviolet
spectroscopy (UV). [15] In the forensic identification of seized drugs, the
minimum standards are: (1) if an analytical scheme uses one validated
analytical technique from Category A, at least another technique from
Category A, B or C is required; (2) if any technique from Category A is not
used, at least two techniques from Category B should be examined, and
one additional test must be performed from Category B or C. [15]
Depending on jurisdictional requirements, the analytes may be
characterized as finished products, intermediates, precursors, key
reagents, or reaction mixtures. [15]

(1) Presumptive Tests
The purpose of a presumptive test is to determine the potential presence
of a substance at a crime scene, it is also called a screening test. [12] The
test can produce a positive, negative, or inconclusive result. In drug
analysis, different types of separate presumptive tests are used in the
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determination of seized drugs and in toxicology. [13] According to
SWGDRUG Recommendations, color tests and immunoassays from
Category C, and thin layer chromatography from Category B are used in
screening tests. [15] Spot tests and thin layer chromatography (TLC) are
the most widely used methods in seized drug detection while
immunoassays are generally applied to human toxicological samples.
Spot tests utilize colorimetric reagents in drug analysis. These reagents
are generally selected because of chemical interactions with reactive
moieties present in the drug. Because of this fact, spot tests lack the
specificity of spectroscopic methods [13,14] have a relatively high limit of
detection [13], and can yield false positive and negative results. Despite
these weak points, spot tests offer rapid answers under field conditions
making them highly useful in drug interdiction. [14] The tests do not
require a highly-trained individual to operate them and generally provide
quick and useful results. A typical colorimetric reagent kit contains nine to
fifteen reagents, and can identify more than 40 of the most common street
drugs. [13] Once a positive result is obtained, subsequent analytical
techniques from Category B and A are required to confirm the drug
determinations. [15]
More sensitive presumptive detection of toxicological samples can be
performed via immunoassay. Immunoassay is an analytical technique
which can detect and qualify the target analyte based on binding to
specific antibodies. In drug analysis, immunoassays are used to detect
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Figure 1.6. A typical set of colorimetric reagents used in narcotics testing. [16] The kits contain
multiple plastic tubes which contains all chemical components required for each colorimetric reagent.
The suspected materials are added to the tubes and colorimetric matching is used to screen for
compounds of interest.
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target drugs in biological matrices. [10] Although Immunoassays higher
specificity and a lower limit of detection than spot tests, they have some
shortcomings. Of most importance is the cross-reactivity, especially for the
metabolites and drugs of similar structure. Cross reactivity can cause
false positive results, particularly when non-controlled substances at high
concentrations react weakly with the test. False negative results can also
occur due to interfering substances in the sample matrix. Another problem
with immunoassays is the administrative detection cutoffs. The response
to each drug can vary depending on the design and manufacturer of the
test. [13,17]

(2) Confirmation tests
All positive results from a screening test require further confirmation.
Confirmation tests utilize a different analytical principle which has higher
specificity and greater sensitivity than screening tests. [13] The tests
commonly utilize separation methods to separate the drugs from samples,
and spectroscopic methods to quantify and identify the components in the
sample. [9] GC/MS and LC/MS are the most common methods used. For
seized drugs, spectroscopic techniques such as FTIR may also be utilized.
[10,15]
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2. Research Goals
In forensic analysis, presumptive tests for drugs of abuse may be
performed on-site or in a laboratory setting. On-site and point-of-care
testing are important to prescreen samples because of the increasing
laboratory backlogs for confirmatory testing. Colorimetric tests and
antibody-based lateral flow immunoassay have been used for years,
however they generally lack multiplex capabilities. Thus, several tests are
required to determine the range of potential analytes.
The goal of the present project was to improve the specificity and
sensitivity of screening tests through the development of a paper-based
microfluidic device for drug detection. Such tests should be inexpensive,
simple to use and rapid in response. Two different paper-based
microfluidic devices were developed. The first device adapted colorimetric
tests to a paper format. Potential analytes included seized drug samples
such as opiates, cocaine and amphetamines. The second type of device
developed for on-site detection of cocaine used a gold
nanoparticle/aptamers complex based on the principles developed in
lateral flow immunoassays.
The colorimetric reagent-based paper microfluidic devices utilized
modified colorimetric reagents with paper chips. Since individually these
tests do not produce high specificity, a multi-channel device can help to
confirm the presence of the target compound through a simultaneous set
of cross-comparisons. Multiple channel also permit a simultaneous
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determination of different classes of drugs. For example, in such a device,
a drug could react with 3 or more of the differing spot tests on a single
device, greatly improving specificity.

As current spot tests are solution

based and often involve harsh acids reacting with metal salts, the
experimental work also included the development of a set of reagents that
utilize alternative oxidants. The overall goal of these studies was to
produce reactions that enhanced the color changes on the devices without
destroying the paper matrix.
A gold nanoparticle/aptamer based paper microfluidic device was also
developed to utilize anti-cocaine aptamers as an alternative to the
antibody based lateral flow immunoassays that are currently used.
Aptamers are useful alternatives to antibody-based assays as they have
high affinity and specificity to the target molecule. Aptamers are DNA or
RNA based oligomers, and they can be chemically synthesized and
modified for use with a variety of colorimetric schemes as biosensors.
Gold nanoparticles change colors resulting from their morphology in
solution (dispersion vs aggregation). Gold nanoparticles easily change
from red to blue under salt-indicated aggregation. The principle of saltinduced color changes of gold nanoparticles can be used to increase
specificity and decrease the limit of detection in the detection of cocaine
and other drug targets. Overall these projects have great potential to
provide improved forensic determinations in on-site drug detection, making
the analyses simpler, more specific and easier to use.
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Chapter 2. Paper microfluidic devices
1. Introduction
Paper microfluidic devices (µPADs) are patterned paper based analyzers
which are designed for use as point-of-care diagnostic devices.
Hydrophobic barriers on the paper channel solvents and analytes to
specific detection regions. Originally, these devices were developed for
use in third world countries where the lack of refrigeration and power for
instrumentation limited diagnostic capabilities. Instead, for µPADs,
reagents are stabilized by being isolated and dried on the paper. They are
then activated as the analyte solution moves up the paper, creating a
system of coupled linear reactions which ultimately result in a color
change as a positive response. No external power is needed.

As a

result, diagnosis can be performed at much lower cost. [1]
The development of such microfluidic systems for laboratory analysis has
the potential to revolutionize analytical procedures, bringing laboratory
operations to the field, and increasing convenience. Microfluidic platforms
can be divided into five groups depending on the method of sample
mobility and fluidic control. These include methods related to capillary
action, hydrostatic pressure, centrifugal force, electrokinetic mobility and
acoustic forces. [2] Paper microfluidic devices are one type of microfluidic
platform, they use capillary and electrokinetic methods for the movement
and analysis of the target of interest. [3]
Paper microfluidic devices utilize paper as a substrate material. The
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development of paper-based chemical testing traced back the work of
Műller and Clegg in the 1940s, who developed paper chromatography.
The usage of paper did not get much attention until Martinez et al.
developed the first paper microfluidic device for chemical analysis. [4] The
first PAD took advantage of unique properties of the hydrophilic channels,
permitting the movement of the sample in a designated direction, resulting
in colorimetric detection at low cost. Since then, there has been an
explosion in the development of applications for paper microfluidic
devices, and many studies of the properties of the paper substrate. [4]
Paper microfluidic devices are small, flexible, portable, and inexpensive to
use. They consume minimal volumes of analytes and reagents and can
be easily stored for long periods of time. The devices have been used in
spot tests and lateral flow analysis methods with chemical and
biochemical targets. [3]

glucose assay

protein assay

1 mm

1 mm

Figure 2.1 An early design for a paper microfluidic device used in
bioanalysis. The device contained detection systems for both glucose and
protein, with each assay having two detection channels. (A) The multichannel design of a µPAD used to detect glucose and protein in urine. The
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figure shows the design of channels and barriers. (B) The color changes
produced by urine applied to the paper-based microfluidic device. When
the urine sample contained glucose and protein, the channel of the
glucose assay turned reddish brown and that for the protein assay turned
green. [1]
A. Paper
Paper can perform capillary action without pumping, improve detection
limits resulting from its high surface area-to-volume ratio, and retain
chemicals within the fiber network. [3] The capillary flow that moves
through a µPAD is a wicking-based flow, so the wicking rate of paper is an
important parameter. Chemicals prepared on µPADs consist of different
types of materials and the durability of the paper is also important.
Therefore, the choice of paper depends on the application and the target
of analysis.

B. Types of µPADs
There are two types of paper-based microfluidic devices: on-demand
devices which are blank platforms without pre-deposited reagents; or
ready-to-use devices, which are designed as complete systems by prior
deposition of reagents into the designed zones of the device. [3] The
ready-to-use devices are used to detect specific analytes in samples.
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C. Preparations and Applications of uPADs
Manufacturing of paper microfluidic devices is very simple and cheap with
an estimated price is < $10 per square meter, even using high-quality
chromatography paper.[1,3,5] Recently published methods include
photolithography, plotting with an analogue plotter, ink jet etching, plasma
treatment, paper cutting, ink jet printing, flexography printing, screen
printing, laser treatment and wax printing.[3] Although each method has
its strengths and weaknesses, wax printing followed by heat based
lamination can quickly and easily produce usable devices using a wax
printer and a laminator.[3,6]
Front

Back

Cross-section

Before Melting

After melting

Figure 2.2 A comparison of the result from melting of wax ink barriers on
chromatographic paper viewing the “front”, “back” and “cross-section” of
the paper. Before melting, the wax ink only appeared on the front side of
the paper; after melting, the wax flowed into the paper (cross-section) and
was visible passing through the paper onto the opposite side. This created
a barrier to the movement of the liquid sample.
The wax printing method was invented in 2009 and takes advantages of
the physical deposition of the wax onto fibrous surfaces for later selective
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hydrophobization [6]. Figure 2.2 demonstrates an example of wax printed
lines. The devices’ patterns can be easily designed and adjusted,
producing devices that are portable, small, and inexpensive. The
procedure used to create these devices are divided into two steps: (1) the
wax patterns are printed on the paper, (2) the wax is melted so that it
spreads horizontally and vertically into the paper. The vertical spreading
creates a hydrophobic barrier within the paper. A byproduct of the
process is a horizontal spreading that decreases the resolution of the
printed pattern, and leads to the wider hydrophobic barriers than the
original printed patterns. (Figure 2.2) This wax printing method has been
successfully used in screening for metal ions [7] and pharmaceuticals
[8,9].
Capillary flow is the basis of the mobility of fluids in μPADs. The
movement can be adjusted by changing the spatial structures and raw
materials during manufacturing. For example, Li and co-workers (2008)
used plasma treatments on μPADs for use in cellulose-based mechanical
switches, filters and separators. [10] The authors prepared chemically
treated filter paper, then used metal masks to produce hydrophilic patterns
via plasma treatments. The plasma treated areas then permitted capillary
flow.
μPADs have been mostly used in biochemical analysis, as well as in
medical and forensic diagnostics. The latest tendency in the development
of these devices is the production of three-dimensional μPADs which can
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be utilized in colorimetric detection and electrochemical detection in the
same paper chip. [11] The application of lateral flow paper
chromatography increases the specificity of μPADs. [4] Most μPADs
utilize colorimetric assays, while others focus on chemiluminescence and
electrochemiluminescence detection techniques. [3]
Above all, paper-based microfluidic devices have many advantages, such
as low material costs, a simple production process, simple designs and
easy interpretations of test results. There is often no requirement for
external instruments or instrumentation. These devices are useful in pointof-care detection of disease, in forensic analysis and in environmental
monitoring.

D. Color Detection
In this project, all tests involved colorimetric detection and the results were
recorded as the pictures for the later instrumental analysis. The color of a
substrate is dependent on the pigments used and the diffuse reflectance
of the colored substrate. The measured signal is produced by the quantity
of incident light that is diffusely reflected by the colored reagents in the
visible range. [12] The observed color is the wavelength of incident light
that is reflected from the substrate, the other visible wavelengths are
absorbed.
Absorbance measurements are described by the Lambert-Beer law for the
determination of quantities of a sample in solution. When paper is used as
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an alternative to solution measurements, the Lambert-Beer law is modified
to predict the diffuse reflectance of a light beam on a surface as a function
of the quantity of a colored species detected. The equation [13] is shown
below:
R = 𝐼$ /𝐼& = 𝑅( 𝑒 *+, 𝐼$ = 𝐼. + 𝐼0 + 𝐼1
in which, R = the reflectance of the incident light by the surface; Ir = the
intensity of the reflected light which depends on the surface of the carrier;
I0 = the intensity of the incident light; Rw = the reflectance of the reference
white surface; k1 = a proportionality constant; m = the mass per unit area
of the substance of interest; Is = the reflection on the surface of the
solution, in the paper test, the value is assumed as a constant; Ic = the
reflection on the white surface of the paper; Ip = the reflection on the
surface of the colored reagent.
Visual identification is dependent on the perception of color by human
beings. Humans have three cone cells in the eyes reflecting short, middle
and long wavelengths. [14] Paper is a scattering material, thus when
colored ink is placed on paper, people observe color because the light is
reflected through the fibers and produces a diffusely-scattered result. [14]
The perceived color of the dyes on the paper results from the wavelengths
of incident light that are reflected following the absorbance of the analyte.
[15]
For color detection methods utilizing cell phones, digital cameras, or
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scanners, quantitative detection is based on reflectance. [16, 17] Usually
the entire sensing area is used to measure the digital color values for the
calculation of calibration curves [18]. RGB intensities are the most
common values used in quantification [19] while chromaticity (hue and
colorfulness) is another choice [20].
It is important to note that humans have varying sensitivity to the color.
Thus to standardize color detection, the idea of a RGB color space was
created to describe the physical color perceived by human eyes with
normal vision.[16] In general the value for red, green and blue as well as
the brightness are used to describe the color components in an image.
[16] In this work, the estimation of the RGB values in a colored image, was
performed using Image J software. Image J software is an open source
software program used to analyze images based on color, pixel value,
angles, and distance. In particular, Image J RGB Measure Plus software
was developed to measure the value of single components of red, green
and blue with a user selected area from a colored image. [17] This
software permits a computer based verification of images taken during the
user’s observation of a color change on the device. It also provides an
instrumental based confirmation of detection.
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2. Goals
The overall goal of the current project was to develop multiplexed paperbased microfluidic devices for forensic drug detection. The novel
development of paper microfluidic devices for drug screening can serve as
a replacement for current colorimetric detection techniques. The key issue
in this project was to modify existing solution-based colorimetric methods
to permit paper-based detection. In addition, tests for interfering
compounds and drug diluents were performed as well as an estimation of
instrumental minimum detectable quantity (MDQ) for the multiple channel
design.

3. Chemicals and Methods
A. Chemicals
All chemicals were analytical grade. Cobalt thiocyanate was purchased
from Aldrich. Cocaine and ketamine were purchased from Sigma (St
Louis, MO). Gold (III) chloride trihydrate (≥ 99.9%) was purchased from
Sigma-Aldrich (St Louis, MO). Sucrose, acetone, chloroform, methanol
and methylene chloride were purchased from Fisher Scientific (Fair Lawn,
NJ). Solid wax inks were purchased from Xerox (Norwalk, CT)

B. Preparation and operation of μPADs
The paper microfluidic devices were printed on chromatographic paper
using a Xerox wax-ink printer (Xerox ColorQube 8570). The paper was
next wrapped in aluminum foil and allowed to pass through a laminator at
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160˚C from two to five times to infuse the ink into the paper and create
hydrophobic fluidic barriers. The colorimetric reagents are then placed at
the designed positions along the fluidic path, and the drugs are spotted in
organic solvents at the bottom of the chip. (Figure 2.3)

Designing((((((((((((((Printing(with(
Heating
through
Designing((((((((((((((Printing(with(
Heating(through(
a laminatorwax(ink
at 160
wax(ink
a(laminar(at(160 C

Heating(through(
Dropping(
a(laminar(at(160
C
chemical(reagents

Dropping(
chemical(reagents

A ready'to'use format

Figure 2.3. Preparation of μPADs. Step 1: Designing via a software
Drawer in Windows system. Step 2: Printing with a chromatographic
paper through a wax-ink printer. Step 3: Heating through a laminator at
160°C for several times. Step 4: Depositing reagents in the designed
positions. Step 5: A ready-to-use μPAD.

The analysis was performed by spotting the dissolved drug onto the chip
or by placing the chip into a solution of the dissolved drug to allow capillary
action to carry it up to the various reaction zones as depicted in Figure 2.4.
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Figure 2.4. Operation of ready-to-use μPADs. The μPADs sat in the vial
containing the moving solution and drug samples. The test stops when
the solution moves to the end of a channel, the operation takes five to ten
minutes.
4. Results and Discussion
A. Effects of µPADs
The channel size and length strongly affects colorimetric development on
µPADs. In this work, it was important to adjust these parameters to
optimize sensitivity and development time. For example, the size of the
chip was important in optimizing analysis time. The longer the channel,
the longer the running time of the paper chip with the same moving
solution. Furthermore, channels facing in a direction counter to the
upwards liquid flow took much longer for the analyte solution to reach the
end of the channel. Depending on the mobility of the solvent, the resulting
analytes may not reach the reaction zone in such designes. These design
considerations must be combined with the chromatographic retention and

27

mixing effects as the solvent front hits each reagent zone. Thus, there are
many critical design issues to consider when optimizing µPAD
development. Figure 2.5 is an example of the effect of the width of
channel on the mobility of the solvent as it delivers the colorimetric
reagent. Gold nanoparticles moved in the desired channels and crossed
the barriers when the top channel was much thinner in Figure 2.5, A and
B. The same gold nanoparticles moved through the channel but these
nanoparticles did not cross the barriers when the channel was wider as
shown in Figure 2.5, C and D.

A

B

C

D

Figure 2.5. The width of moving channels affects the mobility of gold
nanoparticles on µPADs. Left: A thinner channel permits movement of
nanoparticles in 0.3M sucrose solution, the gold nanoparticles crossed the
barriers to the white part on µPADs. Right: A wider channel reduces the
crossing of gold nanoparticles on µPADs.
The saturation of the melted wax into the paper creates a hydrophobic
barrier on the µPADs. Insufficient melting decreases the hydrophobic
properties of the barriers and the moving solution will again cross the
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barrier (Figure 2.6) Therefore, it is critical to optimize the heat of the
laminator.

A

B

Figure 2.6. Effect of melted wax barriers on µPADs design. A: Fully
melted wax barrier. When the moving solution passed through the
channel, the solution did not cross barriers in a properly prepared µPAD.
B: Incompletely melted wax barrier. When the moving solution passed
through the channel, the moving solution leaked across the barrier,
affecting the signal.
The width of the melted ink barriers is also critical. The purpose of the
wax barrier is to prevent the solvent flow outside of the barriers, however
when the barrier was thinner than 0.5mm, the solution crossed over the
barrier and spread over the surface of chips. (Figure 2.7) Optimal widths
ranged from 0.8mm to 1mm.

Color%barrier%width:%0.3mm%

Color%barrier%width:%0.9mm%%%
!

%%

%%

%%%%%%

%

Figure 2.7. The width of barriers affect the control of solvent movement on
the µPADs. When the width of barrier is less than 0.5 mm, the moving
solution can cross the barrier.
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B. Paper
The whiteness of chromatographic paper is a good background for
colorimetric detection. However, chromatographic paper is quickly
degraded by concentrated acids, creating burned areas and dark spots.
Only diluted acids are compatible with chromatographic paper. For
example, 96% sulfuric acid must be diluted to a concentration of 60% or
lower, 56% nitric acid to a concentration of 50% or lower and 37%
hydrochloride acid must be diluted to 35%. However, when these
concentrated acids were diluted with water, most colorimetric reagents
containing strong acids did not produce a chemical reaction. To avoid this
problem, we attempted to use glass fiber filter paper (GF/A, GF/C and
934-AH.) While concentrated sulfuric acid still digested glass fiber paper,
concentrated hydrochloride acid and nitric acid could be used. However,
these three glass fiber filters were too soft to print wax ink on them, and
capillary flow was not optimal. Thus, we needed to develop alternative
reagents/compositions for this application instead of the standard reagents
used in forensic and TLC analysis.

C. Solutions
Traditionally, spot test analysis involves the analysis of target drugs
dissolved in chloroform or methylene chloride in spot tests. To transfer the
colorimetric tests to µPADs, methylene chloride and chloroform were
initially used as carrier solvents. However, the wax on µPADs dissolves
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and spreads when acetone, methylene chloride and chloroform move
through the channel. Methanol dissolves much less ink wax, but it
evaporated before moving to the end of a long channel.

Water is the

best solvent so we examined the potential of aqueous/organic solvent
mixtures.

When acetone is mixed with water at a ratio of 50% and 25%,

the wax barriers remained stable. Acetone was preferable as unlike
methanol it did not produce color changes in the colorimetric test results.
Therefore, paper-based microfluidic devices can utilize wax-inked
chromatographic paper and solutions of acetone/water. Moving solutions
used with gold nanoparticle/ aptamer based paper microfluidic devices
were aqueous, containing only salt and sugar as additives. These mixtures
did not affect the solubility of wax ink on the paper chips.

D. Flow rates
Flow rates on µPADs are dependent on the width of the channel and the
type of moving solution. Four different sizes of chromatography paper
were tested to determine the range of flow rates using a variety of solutes.
(Figure 2.8) In general, the wider the channel, the faster the flow rates on
paper. Pure water has the fastest flow rate on paper chips. When salts
and sugars were dissolved in the moving solutions, the flow rates
decreased. The solutions at higher concentrations produce lower flow
rates.

31

0.5cm

1cm

1.5cm
6cm

3cm
2cm

Moving Solutions

Moving Time (sec)

Figure 2.8 Tests of flow rates with different sizes of paper chips and
different moving solutions.

2000
1500
1000
500
0
Water

0.15mM-Sucrose 0.3mM-Sucrose
2.8MMgCl2/0.15mMSucrose
Moving-Distance-6-cm

2.8M-MgCl2

5.6M-MgCl2

50%-Acetone

Moving-Distance-3-cm

Figure 2.9 Run time of different moving solutions on a channel with a width
of 0.5 cm. Water produced the lowest moving time on the paper.
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Figure 2.10 Run time of different moving solutions as channel width was
changed from 1 to 3 cm. The greatest effect was seen at for the solution
containing the highest salt concentration.
E. Capillary action
To enhance color developments on the µPADs, colorimetric reagents are
used at a much higher concentration on the µPADs than in solution tests.
The solvent migrates via capillary action in a forward direction and the
color changes occur as reagents are mobilized and mixed together with
the analyte in the reaction zone. However, when concentrated reagents
are used it is possible that osmosis can occur, with the result that
reagents may also flow counter to the moving channel. This effect can
produce color changes in the solution channel instead of the detection
zone. (Figure 2.11, Left) A wider solution channel can decrease the
backflow of the reagent to the solution channel. (Figure 2.11, right)
Therefore reagent concentration is a critical parameter to avoid backflow
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due to osmotic effects, and the effect of backflow can be decreased
through modification of the width of moving channel.

(a)

(b)

Figure 2.11 Backflow of colorimetric reagents. (a) Left: The pink reagent
moved from the top ball back to the end of the moving channel; Right: the
color change reaction occurred in the moving channel instead of in the
reagent ball; (b) Left: The pink reagent moved little from the top ball into
the moving channel; Right: The color change again occurs in the solvent
channel. The thinner channel (Left) has a greater backflow effect than the
wider channel (Right).
5. Conclusions
A number of different factors affect the colorimetric detections on µPADs.
The optimization of ready-to-use formats and the applications are related
to the designs, ink wax, moving solutions and reagents. The optimal
format considers the shape, size, direction of channels. Chromatographic
paper is a good substrate to the colorimetric detection, and a wellprepared pattern contained a fully melted wax ink. The moving solution
should be safe to the melted wax on µPADs. To minimize the moving
time, the main moving channel should be as wide as the design possible,
meanwhile, the moving solutions should have a low concentration; the
barriers keep 0.5 mm or higher.
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Chapter 3. Colorimetric reagent based multiple channel paper microfluidic
devices
1. Introduction
A. Spot Tests
Colorimetry is defined as a method in which the analyte reacts with a
proper reagent and produces a unique and visible colored product. [1] It is
used in qualitative analysis to identify the presence of analytes in simple
and complex matrices. The observation of colors is subjective, so the
operators usually require reference standards to compare with the results.
A spot test is an important type of the colorimetric measurement used in
the preliminary identification of seized drugs. [2] A series of reagents are
used to react with a single atom or functional group. For example, the
Marquis test causes a yellow-brown color with nitrogenous bases and the
Simon’s test produces a blue color with a secondary amine. [1]
Colorimetric reactions have been known for many years, many of which
have been developed for 30, 40 [3] or even up to 70 years [4]. Some
reagents were developed to detect a single chemical, but they more often
react with multiple compound or materials.
In 1987, the Division of Narcotic Drugs invited an expert group to
summarize a list of colorimetric tests with seized drugs, including details
on the mechanisms and cross reactants. [5] The listed procedures include
methods for the detection of opium, morphine, codeine, methadone,
amphetamines, cannabis, barbiturates, diazepam and benzodiazepine
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derivatives, lysergide, cocaines, phencyclidine, and others. [5] Later in
2000 the National Institute of Justice, Law Enforcement and Corrections
Standards and Testing Program published a standard of the Color test
reagents/ kits for preliminary identification of drugs of abuse. [6, 7] The
standard listed the preparation of 12 colorimetric reagents (Table 1) and
the color changes that occur in the presence of illicit drugs and
adulterants, the drug detection limit, and the safety of the chemicals. The
in-laboratory preparation of spot tests is more common in research labs
than in government labs where, because of the necessity for validated, onsite measurements, the operators use colorimetric reagents from kits sold
by various manufacturers. The reagents are stored in closed tubes or
vials and the operator follows specified procedures, adding the samples to
two or three tubes and observing the color changes. Results are read
using the colorimetric charts to minimize the possibility of false positive
detection of the drugs. (Figure 3.1)
Spot tests have been used for years in presumptive drug testing because
they are rapid and inexpensive, however, they have several
disadvantages. Most importantly, spot tests have low specificity as they
mainly react with functional groups on the compound of interest [1, 6, 7, 9].
This characteristic can result in false positive results with other members
of a drug class or common powders. [7] Thus it is important that the
results of these tests be verified using more specific techniques to avoid
improper prosecution of innocent individuals. [10] Because these tests
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Suspected Solids
+ Marquis Reagent
Positive

Negative

Methylenedioxy-substituted cathinones
Opiates
Nexus
Ring-substituted amphetamines or methorphan
Amphetamines
+ Simon’s Reagent
Positive
MAMA/MDEA/MBDB

+ Simon’s Reagent

Negative

Negative

MDA or
Methoprhan

Amphetamine

Positive
Methamphetamine

Inconclusive
Scott’s Reagent +
Positive

Negative

Cocaine

Inconclusive

Chen-Kao Reagent +
Positive
(Pseudo)ephedrine

Negative
Inconclusive

Libermann’s Reagent +
Positive
Cathinone Analogue

Negative
Inconclusive

Figure 3.1. A flow chart for colorimetric drug analysis. [8] The boxes
indicate the color change possible with each specific drug. The Marquis
reagent is used in the first step which produces a specific color change for
five different drugs, while the white boxes indicate negative results.
Scott’s reagent is used in the second step, with a pink color indicating
negative results, and a blue color indicating a positive result. The ChenKao reagent is the third test, with a purple color indicating a positive result
and a blue color indicating a negative result. Libemann’s reagent is used
in the fourth test, and the yellow color indicates a positive result. Simon’s
reagent is used to further differentiate compounds which are positive for
the Marquis reagent.[
also have a lower sensitivity than other screening methods, most
applications focus on seized drug analysis instead of toxicological
detection. [2, 7] Many colorimetric reagents contain concentrated acids
(96% H2SO4, 68% HNO3, 37% HCl) and toxic organic solvents (Table 1)
[6, 7]. For example, in the Duquenois -Levine test, chloroform, a suspect
carcinogen and liver toxin is used to extract drugs from the reagent to
display a color change [6]. Because such tests are often accessed by
poorly trained individuals, more convenient and safer procedures are
needed.
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B.

Drug detection

Each colorimetric reagent has their mechanism and targets. Some
reagents are designed to detect a single drug; others are available to
several drugs Commonly, Mayer, Wagner, and Dragendorff reagents can
detect alkaloids. For example, the Marquis reagent detects opiates, the
cobalt thiocyanate reagent detects cocaine, Duquenois reagent and the
Fast Blue B reagent detect Marijuana. [9] In this project, an effort was
made to produce colorimetric detection on a heterogeneous paper based
device by modifying and applying these solutions based reagents to the
solid support. Key issues included optimization of reactants to permit
drug determination without damaging the paper substrate, as well as
producing a format where the reagents can be isolated and stabilized prior
to analysis.

a.

Cocaine detection

In spot tests, cocaine HCl in chloroform produces a greenish blue color
with cobalt thiocyanate and HCl, or produces a dark orange-yellow color
with cobalt thiocyanate dissolved in water. These tests are performed
using the Scott reagent, a mixture of 2% cobalt thiocyanate in water and
glycerine (v:v=1:1). Cocaine reacts with both cobalt thiocyanate reagents
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to produce a blue complex from an initially pink solution. The chemical
mechanism [5] is as follows:
[Co(SCN)(H2O)5]+ + 3SCN- + cocaine ↔ Blue complex

The generic cobalt thiocyanate produces a similar greenish blue color with
heroin HCl, propoxyphene, hydrocodone tartrate, and another 54 drugs in
the chloroform solution. [3] Therefore, the Scott reagent was developed
which is more specific for with cocaine. [11] Houck has mentioned that the
blue-color changes can turn back to pink after adding concentrated
hydrochloride acid, and will turn to blue again if a chloroform extraction is
performed. [11] Deakin reported that cobalt thiocyanate produced a blue
color with cocaine HCl, but no color changes with cocaine free base. [12]
Only the addition of concentrated acids lead to a blue color for free base
cocaine using this cobalt thiocyanate reagent.
The Mandelin reagent is a mixture of ammonium metavandate and
concentrated sulfuric acid. The fresh reagent has a strong yellow color. It
reacts with more than 100 drugs and the resulting final products yield a
variety of colors. For example, a brilliant orange-yellow color is produced
with methylphenidate and an orange color with ketamine. [3]
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b.

Ketamine detection

The Mandelin reagent also works with ketamine and the color change is
from yellow to orange [7], but the Mandelin reagent has a high toxicity. In
2013 Gupta et al. modified the cobalt thiocyanate complex with bases to
permit the colorimetric detection of ketamine hydrochloride. [13] The
cobalt (II) complex reacts with the thiocyanate to an octahedral complex of
[Co(SCN)4]2-, and the complex is stabilized by the two hydrophobic cations
in the coordination sphere. (Figure 3.2)

[Co(SCN)(H2O)5]+(aq) + 3SCN-(aq)

[Co(SCN)4]2-(aq) + 5H2O

Cl

Cl

[Co(SCN)4]2-(aq) + KOH + 2

H 2N

HN

O

O

Co(SCN)4

2
Complex

Figure 3.2. Mechanism of Cobalt thiocyanate complex reacting with
ketamine. [13]
c.

Codeine/ morphine detection

Both Codeine and morphine are alkaloids extracted from opium. The most
common spot tests for these opioids include concentrated nitric acid, ferric
sulfate, Marquis reagent, Mecke’s reagent [5], and Froehde reagent [6].
Opioids can react with concentrated nitric acid and the final products are
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nitrated opioids which form a hydrogen bond between the nitro group and
the hydroxyl group. [5] Nitrated morphine produces an orange-red color
while nitrated codeine produces an orange color.[5] Ferric sulfate has a
positive reaction with the meconic acid in opium resulting in a purple color
change. [5, 6] The Marquis reagent produces a purple color with both
morphine and codeine. [6] (Figure 3.3) Mecke’s reagent when mixed with
codeine and morphine produces a dark bluish green color. [7] (Figure 3.4)
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Figure 3.3. Mechanism of Morphine reacting with Marquis reagent.[14]
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Figure 3.4. Mechanism of Morphine reacting with Mecke’s reagent.[5]
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Froehde’s reagent (Table 3.1) is used to detect the benzomorphan class
of alkaloids, especially opioids. It turns a dark green color with codeine
and a dark purplish red with morphine. [6] The mechanism is not well
studied, but it produces a color change that ranges from pink to purple
when applied to alkaloids. [7] Ipecac alkaloids and opium alkaloids react to
a purple-bluish-violet color using this test. [15]

d.

Amphetamine/ Methamphetamine detection

The Marquis’ Reagent, sulfuric acid, Simon’s reagent, Simon’s reagent
with acetone and Vitali-Morin’s reagent are common colorimetric reagents
for the detection of amphetamines and other amphetamine derivatives.
The Marquis’ reagent gives an orange color with amphetamine and a
yellowish green color with methamphetamine. [5, 6] (Figure 3.5) Simon’s
reagent reacts with secondary amines (Figure 3.6) and gives a blue
Simon-Awe complex with methamphetamine. [5, 6] Acetone can replace
acetaldehyde in the Simon’s reagent, this alternative works selectively with
primary amines. [5] (Figure 3.7)
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Figure 3.5. Mechanism of Amphetamine (R = H) and methamphetamine
(R = CH3) reacting with Marquis’ reagent.[5]
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Figure 3.6. Mechanism of methamphetamine reacting with Simon’s
reagent of aldehyde. [5]
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Figure 3.7. Mechanism of Amphetamine reacting with Simon’s reagent of
acetone. [5]
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Figure 3.8. Mechanism of methamphetamine reacting with Fast Blue B
reagent. [5]
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Additional test reagents include Fast Blue B reagent which has been used
to detect THC in marijuana [16] (Figure 3.8) and FeCl3 which gives a color
change from yellow to green with amphetamine. [17]
Colorimetric reagents are designed to for use with liquid solutions. When
these same reagents are applied for use with paper microfluidic devices,
many are not suitable. As shown in Table 3.1, most colorimetric reagents
used in drug testing, such as Mandelin and Marquis reagents, use
concentrated acids in the solution tests. However, these acids can
degrade chromatography paper. Thus, it is necessary to develop an
alternative to these strong acids. Some reagents, like the Zwikker
reagent, require mixing two solutions to create new complex which gives a
color change with the addition of specific drugs. However, this type of
complex is unstable and typically requires fresh preparation prior to use.
Other reagents use organic solvents, such as acetaldehyde and
chloroform. These organic rapidly evaporate in air, and will also not work
with paper chips. The reagents also require modification before they can
be applied to the paper devices.

2. Goals
The goal of this project was to prepare a multiple-channel paper chip for
the presumptive determination of seized drugs. The project was
separated into four tasks. First, the colorimetric reagents had to be
modified to permit their use with chromatographic paper instead of liquid
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solutions. Second, the cross-reactivity and interferences of the modified
colorimetric reagents on µPADs needed to be cataloged. Third, an
estimation of figures of merit including instrumental minimum detectable
quantity (MDQ) needed to be determined. Fourth, the final development
and validation of a multi-channel device for drug detection needed to be
completed.

3. Chemicals and Methods
A.

Chemicals

All chemicals were analytical grade. Cobalt thiocyanate was purchased
from Aldrich; iron (III) chloride and glycerol were purchased from Acros
Organics (Waltham, MA, United States); fast blue B, molybdic acid and
ninhydrin were purchased from Sigma-Aldrich (St. Louis, MO, Unites
States); potassium permanganate, sodium hydroxide, hydrochloric acid,
and acetone were purchased from Fisher (Pittsburgh, PA, United States).
Amphetamine, methamphetamine, cocaine, ketamine, ephedrine were
purchased from Sigma (St Louis, MO, United States). Morphine, codeine
and thebaine were purchased from RBI (Natick, MA, United States). The
standard solutions of drugs were prepared as 100mg/mL in 50% acetone/
50% deionized (d.i.) water.
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B.

Designs of Paper Microfluidic Devices

A six-channel paper microfluidic device was designed to detect several
psychotropic compounds as followed: cocaine, ephedrine, morphine,
ketamine, amphetamine, methamphetamine and MDMA.
The paper chip was developed following single tests, and each channel
contained different amounts of the reagent area. (Figure 3.9) According
to the final colors, the format used the color of yellow, other colors like
black, blue, green and red could produce misleading phenomena to the
naked eyes. The words next to each channel indicated the possible drugs
with the positive results for each channel, the color of the terms described
the positive color changes.

Figure 3.9: Six channel device developed for sample analysis. The device
consists of six channels with one or two zones for placing reagents. The
solid sample is dissolved in solvent and introduced at the bottom of the
device using a paper tab placed in a vial. Alternatively, the solids can be
added to the middle channel. Capillary action mobilizes the drug and the
solvent mixture up into the reaction zones. Dashed areas indicate the
image region used for the colorimetric detection by eye or cell phone
camera. Cod = codeine, Coc = cocaine, Ket = ketamine, Morp =
morphine, Amp = amphetamine, MA = methamphetamine, Eph =
ephedrine, The = thebaine.
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After the final design was obtained, the format was printed on
chromatographic paper (Whatman No.1, GE Healthcare, UK) using a
commercial wax printer (Xerox Color Cube 8570, Xerox, US). Next, the
paper was wrapped in an aluminum foil package and passed three to five
times through a laminator at 160 °C, at a speed of 1.6 cm/sec (Tamerica
Tashin Industrial Corp, TCC-6000). The wax melted from the surface to
the back of the chromatographic paper and created the hydrophobic
barriers.
The design of each channel can detect a different set of compounds with
unique colored responses depending on the modified reagents. Figure 3.9
illustrated the design of the chip, and the number indicated each channel,
and the letters identified the potential locations for each reagent. Samples
and reagents were prepared in different locations to optimize the color
generation, sensitivity, reaction time and system stability.
Lane 1 (L1 in Figure 3.9) prepared to detect ephedrine, MDMA and
methamphetamine in unknown samples. In this lane, 0.5 µL of a mixture
containing 100 mg/mL sodium sulfate and 10 mg/mL Fast Blue B were
deposited to zone A. Lane 2 (L2 in Figure 3.9) was used to detect four
compounds, cocaine, codeine, thebaine, and ketamine. Also, 0.5 µL of a
mixture containing 100 mg/Ml cobalt (ii) thiocyanate and glycerol (v:v=3:2)
added to zone A. Lane 3 (L3 in Figure 3.9) could identify codeine, MDMA,
morphine and methamphetamine. One mg of potassium permanganate
was crushed by a spatula onto L3 zone A and 2 µL of 1 mg/µL molybdic
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acid were added to L3 zone B. Lane 4 (L4 in Figure 3.9) detected
ketamine by using 0.5 µL of 0.02 mg/mL of sodium hydroxide in zone B
and 0.5 µL of 12.5 mg/mL cobalt thiocyanate in zone A. Lane 5 (L5 in
Figure 3.9) was designed to detect amphetamine with the separate
deposition of 0.5 µL of 50 mg/mL ninhydrin in 50% acetone and 1M NaOH
in zone A. Lane 6 (L6 in Figure 3.9) detected morphine and MDMA. 0.5
µL of 100 mg/mL FeCl3 added to zone A. Finally, the bottom tip of the
device would be placed in a carrier solution of 300 µL of 50% acetone in
water, and capillary action would move the drug and the solute to the end
of each channel.

C. Estimation of instrumental MDQ and visual LOD
For the solution limit of detection by eye, single lane paper microfluidic
devices were set in the sample bottles. The drugs were dissolved in
acetone:water (v:v=50:50). When the paper devices were place in the
bottles, the solutions moved through the channels and produced the color
changes at the end of the channels. (Figure 3.10)
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Figure 3.10. A solution test for determination of limit of detection. The
cocaine concentrations used in this test were 0, 200 µg/mL, 400 µg/mL,
600 µg/mL, 800 µg/mL, 1000 µg/mL from left to right.
The calculation of MDQ was carried out using the single lane devices and
the analysis by software Image J. The sample bottles contained
acetone/water solvent. The drugs were dissolved in acetone/water, and
were placed on the middle of the channel. When all solutions on the
paper chips dried, the paper chips were placed in the carrier solution vials
and the drugs on the paper moved up the chip via capillary flow. When
the drug reached the terminal end of channel, the color change
immediately occurred. The calculation of minimum detectable quantity
(MDQ) was performed using pictures recorded by an 8-megapixel camera
attached to a Nexus 5 (LGE) smartphone. The microfluidic devices were
photographed on a white background and with a flash from the
smartphone camera to avoid the external light contamination. All paper
microfluidic devices were kept at a distance of 6 cm between the camera
and the background.
The intensity of the red (R), green (G), blue (B) and RGB components was
used in data analysis by Image J software version 1.48. Equation (1)
calculated the proportionality between the color components and the
absorbance:
𝐴3 = −𝑙𝑜𝑔

89
89,;

= - 𝑙𝑜𝑔𝑅< (1)

in which Ax was the absorbance of X, Ix was the intensity of color
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component, Ix,w was the intensity of the blank spot, Rx was the reflectance
of light X and C was the concentration of X.

Estimation of MDQs was performed using a modified device in which an
additional Position A was added to permit the deposition of 0.5 µL of a
standard sample upstream of the colorimetric reagents. 0.5 µL of a variety
of standard solutions containing 1 to 100 mg/mL of each drug was added
to the sample area of each lane (A zones – Figure 3.11) Each test was
repeated three times. Quantitative measurements were taken at the end
of each channel (Position D in Figure 3.11). The absorbance of each drug
sample was proportional to the quantity of the drug, and the minimum
detectable quantity was estimated as three times the standard deviation of
the intercept divided by the slope of the calibration line.

Figure 3.11. Multi assay presumptive test of a six-lane device for MDQ
estimation. Position A: Sample area; Position B, C: Reagent areas.
Position D: End part. Lane 1: Modified Fast Blue test. Line 2: Modified
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Frohdles test. Line 3: Modified Scott reagent test. Line 4: Ninhydrin test.
Line 5: Cobalt thiocyanate/ NaOH test. Line 6: Modified iron (III) chloride
test.
D. Interference tests
Lidocaine and procaine were purchased from Acros Organics (Waltham,
MA, United States), quinine was purchased from J. T. Baker Inc.
(Philipsburg, NJ, United States) and caffeine was purchased from SigmaAldrich (St. Louis, MO, United States). Dimethylsulfone, lactose, mannitol
and inositol were obtained from Fisher (Pittsburgh, PA, United States).
King Arthur gluten-free flour, Arm & Hammer baking soda, Publix
granulated sugar, Rumford aluminum free baking powder, Shower Bath
Salt absorbent body powder, iodized salt, (Publix antacid tablets), and
Argo 100% pure corn starch were purchased from supermarkets in Miami,
FL, United States. Before analysis a solution or slurry of each interference
was prepared at a concentration of 100 mg/mL in 50% acetone /50%
deionized water.
The device used in interference tests used the design in Figure 3.11.
Each sample was deposited in zone A, and the moving solution of 50%
water transferred the sample to the end of the channels and produced
positive/negative results
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4. Results and Discussion
A. Modifications of Reagents for SAMHSA-5 drugs
(a) Modifications of Scott’s reagent for cocaine detection
The Scott reagent was designed for specific detection of cocaine, but we
found the reagent produced an incomplete result with cocaine free base in
the solution test. The original method required the addition of concentrated
hydrochloric acid and chloroform to create a bilayered extraction and the
positive color blue color change appeared in the organic phase. Deakin
found that cocaine free base itself did not produce a blue color with Scott
reagents, and cocaine in both its acidic and free base phases produced a
blue color change with the addition of concentrated acids.[12] However,
concentrated acids, from 98% sulfuric acid, 68% nitric acid to 37%
hydrochloride, degrade chromatographic paper and cannot be directly
applied to paper microfluidic devices. Dilution of the acid was one option.
Experiments were performed using concentrated hydrochloric acid diluted
to 24%, 13.5%, 6.5%, and 3.7% with d.i. water. The result was then
examined for use on the paper devices. All solutions produced a blue
color change with the Scott reagent in the solution tests when cocaine was
added. However, when the modified Scott reagent was mixed with 3.7%
hydrochloride, it produced a positive result with several psychotropic
compounds including Morphine, MDMA, amphetamine,
methamphetamine, ketamine, ephedrine, cocaine, codeine, quinine, and
procaine.
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Figure 3.12. Blank (left), cocaine (right, 1 mg/mL) was added to the Scott
reagent (2 g Co(SCN)2, 48 mL glycerol, 50 mL H2O).
In the original Scott reagent test, chloroform is the solvent for the cocaine
solid. Chloroform is toxic and a carcinogen, and is a poor choice for
usage in the field test. Furthermore, chloroform dissolve the wax on paper
microfluidic device. An alternative method involves the use of methanol
and acetone as a solvent. These solvents can be mixed with water,
eliminating problems with dissolution of the wax barriers of the hydrophilic
channels. In our design, we utilized organic solvents to adjust the capillary
action of solutions of drugs on paper microfluidic device. In our work, it
was important to catalog differences in color development caused by
changes in organic solvent composition. When solid cocaine was
dissolved in 50% acetone and 50% methanol, the acidified Scott reagent
still produced a blue color from the red reagent. An interesting result was
obtained when the reagent was used with ephedrine. Deakin reported that
ephedrine HCl produced a quickly-disappearing light blue color with the
Scott reagent, and the presence of concentrated hydrochloride can make
the color change stable in aqueous solution. [12] We examined the results
of this test with ephedrine hydrochloride in 50% acetone. The result was
a green color, however, when dissolved in 50% methanol, the same
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reagent produced a purple color.

Figure 3.13. Color change observed for the modified Scott reagent. Left:
ephedrine/methanol; Right: ephedrine/acetone. Ephedrine: 1mg/mL
This reagent did not work with cocaine free base in solution but it did work
on paper microfluidic devices. However, the color produced was light and
difficult to distinguish from the paper background. As a result, a set of
solutions including 2%, 4%, 6%, 8%, 10%, 12%, 15%, 20% (w/v) cobalt (II)
thiocyanate were examined for color changes, when the concentration
increased to 8%, the blue color changes were easy to observe (Figure
3.14); but when the concentration were higher than 12%, the blue color
was hidden in the original dark red color.

Figure 3.14. Color change observed for the modified Scott reagent on
paper microfluidic device. Left: Blank test. Right: Cocaine test, cocaine
1mg/mL in 50% Acetone.
(b) Modifications of basic Scott reagent for ketamine detection
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The published method for detection of ketamine hydrochloride used 0.1M
cobalt tetrathiocyanate/ ethylene glycol and 0.1 KOH solution. [12] In the
solution tests, we prepared a mixture of cobalt thiocyanate and sodium
hydroxide, and the tests did not work with ketamine hydrochloride. The
cobalt thiocyanate appeared as red in the aqueous solution, and it
changed to green following the addition of NaOH. Ketamine hydrochloride
was continually added to the mixture, and the solution remained green.
We found that additional hydrochloride was necessary to produce the
same purple color change in the solution tests as the paper described. [13]
A higher concentration of reagents was next used to increase the intensity
of the color on paper chips. The modified thiocyanate reagent was used
at a concentration of 125 grams/L; the sodium hydroxide was 2% (w/v).
When the test was applied to paper microfluidic devices, a solution
containing 10% Co(SCN)2/ NaOH was deposited on the paper (Figure
3.15, Mid, Zone B), and when the ketamine solution moved up the channel
to the reagent position, no color change occurred. A modified design
incorporating three sequential zoned for reagents was developed to
optimize this process, (Figure 3.15). When the Co(SCN)2 was added to
position C and the NaOH added to Position B, the ketamine sample
moved through the channel and no color change occurred. When the
NaOH solution was deposited on position C and the Co(SCN)2 deposited
on position B, the ketamine produced a unique purple-blue color in the
Co(SCN)2 zone. (Figure 3.15, Mid) Dubey et al. described a ketamine test
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reagent based on the use of a basified Scott reagent.[13] In this test, the
order of addition of the chemicals did not impact the color change.
However, when used in the µPADs, the ketamine must react with NaOH
before moving to the Co(SCN)2 area. The presence of 3.7% hydrochloride
created a blue-color change under the same conditions. (Figure 3.15,
Right)

w/out&HCl

w/HCl

Blank&&Ket

Ket w/HCl

Figure 3.15. Color change observed for the ketamine test. Ketamine
(Ket): 50 mg/mL.
(c) Modifications of Frohde’s reagent for codeine detection
The original Frohde’s reagent consists of concentrated sulfuric acid and
molybdic acid. Chromatographic paper cannot survive from the presence
of concentrated sulfuric acid. Dilution of the 96% H2SO4 to a lower
concentration eliminated the colorimetric response. In general, this test
did not work when the concentration of acid was lower than 96%.
Concentrated sulfuric acid is commonly used as an oxidizer or a strong
acid. To test the potential that the role of sulfuric acid was as an oxidizer
and not a proton source, molybdic acid was treated with concentrated
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nitric acid and concentrated hydrochloride acid and used in the test format
with codeine. Since neither acid produced a color change, it was likely
that concentrated sulfuric acid was acting as an oxidizer in the reagent.
Several strong oxidizers were next examined, however only potassium
permanganate combined with molybdic acid produced a color change
when combined with different drugs. The blank test produced a purple-red
color which results from the permanganate in the solution. Following the
addition of codeine, the color of the solution changed to a brown-yellow
color. This brown-yellow color likely results from a complex of molybdateoxidized codeine coupled with the manganese ion (Mn2+). The
mechanism was assumed as follows:
Morphine + KMnO4 + MoO3
–> Mn2+ + MoO42- + Product from oxidation/complexation with codeine

Figure 3.16. Color change observed for the codeine test. Blank (left),
codeine (right,2.5 ɥM) was added to molybdic acid dissolved in
KMnO4/acetone at 5 ɥM - 2.5 ɥM). On the paper, oxycodone in acetone:
H2O (10 mg/mL) was screened using KMnO4 and molybdic acid pastes.
When the test was transferred to the paper microfluidic device, the reagent
produced a purple-red color. However, this mixture oxidized in air when
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deposited on paper changing to red in ten minutes and then continuing to
oxidize to brown color over a period of one hour. Even when prepared
and protected in the sealed packages oxidation occurred within a day.
However, when the reagent was prepared as a paste, the test worked.
The order of placement of the reagents on the paper chip was also
important.
In these experiments a sample of codeine was dissolved in 50% acetone
and was placed at the bottom of the chip. It then moves up the lane via
capillary action towards the reagent zones.

When the chip was prepared

by deposition of permanganate upstream of the molybdic acid, the purplered color migrates upward, covering all spaces in the chip, making it
difficult to detect the color change produced by the molybic acid.
However, if molybdic acid was deposited upstream of permanganate, a
proper color change was observed.

(d) Modification of Iron (II) Chloride for the morphine test
The original iron chloride test involves the reaction of ferric chloride with
morphine which produces a color change from yellow to green. Ferric
chloride was dissolved in water at concentrations of 10mg/mL, 30mg/mL,
50mg/mL, 700mg/mL, 100mg/mL and applied to µPADs, with the
deposited reagent appearing as yellow spots at the end of channel (Figure
3.17, Left). A concentration of 100mg/mL produced the darkest green with
a morphine sample of 1mg/mL. (Figure 3.17, right)
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Figure 3.17: Color change observed for the morphine test (right) and a
!
blank (mid)
(e) Modification of Ninhydrin for the amphetamine test
The ninhydrin /NaOH test designed for amphetamine included three steps:
(1) ninhydrin was dissolved in acetone/water at a concentration of
50mg/mL and the solution was dropped to the end of the channel and
dried; (2) a sodium hydroxide solution of 1M was spotted on top of the
ninhydrin; (3) amphetamine was dissolved in an acetone/water (v:v=50:50)
1mg/mL of amphetamine in 50% acetone of 300 µL was prepared in the
carrier vials. When the paper chip dried, it was placed in a vial, and
capillary action moved the sample to the end of the channel. The color
change of amphetamine was from light yellow to purple.

!!!!!!!

!

!Figure 3.18: Color change observed for the amphetamine test (right) and a

blank (mid)
(f) Modification of Fast Blue B for the MDMA and methamphetamine test
The Fast Blue B/ Na2SO4 test designed for methamphetamine and MDMA
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included three steps: (1) 1µL of a Fast Blue B solution of 10mg/mL was
spotted on the end of the channel and dried; (2) 1µL of a Na2SO4 solution
of 100mg/Ml was dropped to the position of Fast Blue B; (3) MDMA and
methamphetamine were separately dissolved in a acetone/water
(v:v=50:50) solution. A 300 µL of 1mg/mL methamphetamine in 50%
acetone was prepared in the carrier vials. When the paper chip dried, the
paper chip sat in the vials and capillary action moved the sample to the
end of the channel. The color change of methamphetamine was from
yellow/brown to orange. (Figure 3.19, upper) 1 µL of 1mg/mL MDMA
added in the middle channel under the Fast Blue B spot, 50% acetone
moved the sample to the end of the channel and produced a color change
from yellow/brown to red/brown. (Figure 3.19, bottom)

!
Figure 3.19: Color change observed for the detection of
Methamphetamine (top) and MDMA test (bottom) a modified Fast Blue B
reagent was used.
B.
Estimation and Determination of MDQ and LOD
The minimum detectable quantity (MDQ) for the drug detection was
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calculated using the amount of drug necessary to produce a color change
on each µPAD. Each test was repeated three times. Image J software
was used to calculate the intensity of the red, green, blue and RGB
components of the area of each reaction (end of each lane – Figure 3.11)
from the images produced by a Nexus 5 (LGE) smart phone. The resultant
signals were plotted as a function of the quantity of drug using eqn (1),
Figure 3.20. Ephedrine, methamphetamine and MDMA produced the best
linear relationship using the absorbance of blue components and the drug
quantity. Amphetamine, ketamine and morphine respectively produced an
optimal response with the green, RGB and red component. The value of
the instrumental MDQ was estimated as three times the standard
deviation of the intercept divided by the slope of the calibration curve.
C.

Cross-reactivity and interferences

Cross-reactivity tests were designed to test the response of the
colorimetric reagent paper chips with cocaine, ketamine, ephedrine,
MDMA, amphetamine, methamphetamine, codeine, morphine and
thebaine. All color changes were labeled in Table 3.3, and the falsepositive tests of common powders and controlled substances were listed
in Table 3.4. The paper chips containing the modified Scott’s reagent and
the modified Morris reagent reacted with almost all drugs listed in Table
3.4. Only ketamine produced a distinct purple color, while the rest of the
drugs produced a blue color. Since these two paper chips did not react
with common powders, they could only be used to narrow the range of
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types of drugs, but they cannot identify a single drug. Fast Blue B reagent
based paper chips only produced results with MDMA, methamphetamine,

Figure 3.20. Application of ImageJ software for the detection of various
drugs on the µPAD device. Pixel colors are indicated on the Y axis.
Linearity ranges: (a) amphetamine; (b) ephedrine; (c) MDMA; (d)
ketamine; (e) morphine; (f) methamphetamine. (n=3)
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ketamine and procaine. All gave the same orange color. The FeCl3
reagent based paper chips produced different color changes when treated
with MDMA, ephedrine and morphine. Ninhydrin reagent based paper
chips produced results with amphetamine.
In order to test for interferences, nine commercial products including flour,
baking soda, sugar, baking powder, bath salt, body powder, table salt,
antacid and corn starch were tested to determine if false positive
responses occur. Among the tested products, the baking soda reacted
with Fast Blue B reagent, turning to brown. Most of the common diluents
used to cut illicit compounds (quinine, lidocaine, procaine, caffeine,
dimethylsulfone, lactose, sucrose, mannitol, and inositol did not react with
test reagents. However, procaine did produce a combination of colors
close to that of methamphetamine (Table 3.4)
Additional tests of drugs and interferences with the multiple channel chip
design were performed by Giacomo Musile (Figure. 3.21). [17]

Figure 3.21 A demonstration of the µPAD developed to detect
interferences: From left to right: Modified Scott’s reagent channel,
ninhydrin reagent channel, Fast blue B reagent channel, ferric chloride
channel, permanganate/ molybdic acid channel. The results show a
comparison of a blank chip (left) and a chip exposed to a sample of
quinine (right), with a resulting change in the color of the modified
Scott’s reagent.
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Table 3.4. False positives: Common powder, diluents and adulterants
R#1

R#2

R#3

R#4

R#5

R#6

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

Winn Dixie Iodized Salt

NCC

NCC

NCC

NCC

NCC

NCC

Antacid Tablet

NCC

NCC

NCC

NCC

NCC

NCC

Blank Solution
Positive Solution
Common Powder
King Artur Flour Gluten Free
Multipurpose Flour
Arm & Hummer Pure Baking
Soda
Publix Pure Granulated
Sugar Extrafine
Publix Confectioners Sugar
Rumford Aluminium Free
Baking Powder
Shower Bath Salt Absorbent
Body Powder
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R#1

R#2

R#3

R#4

R#5

R#6

Quinine

NCC

NCC

NCC

NCC

NCC

Lidocaine

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

NCC

Dimethylsulfone

NCC

NCC

NCC

NCC

NCC

NCC

Lactose

NCC

NCC

NCC

NCC

NCC

NCC

Sucrose

NCC

NCC

NCC

NCC

NCC

NCC

Mannitol

NCC

NCC

NCC

NCC

NCC

NCC

Inositol

NCC

NCC

NCC

NCC

NCC

NCC

Starch

NCC

NCC

NCC

NCC

NCC

NCC

Adulterants

Procaine
Caffeine

NCC

NCC

NCC

Diluents

*R#1: Fast Blue B Reagent; R#2: FeCl3 Reagent; R#3: Ninhydrin
Reagent; R#4: Modified Scott’s Reagent; R#5: Modified Morris
Reagent; R#6: Modified Froehde's Reagent. NCC: no color
change.
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Although some of the drugs had the same color change with one reagent
on the paper chips, the multi-channel paper chips permitted a far more
specific determination of the unknown compounds through the use of the
cross-reactivity chart. Figure 3.22 is an example of an application
involving the determination of morphine. For this chip, Lane 3, the
modified Froehde turned red; Lane 4, the basified cobalt thiocyanate
turned blue, and lane 6, Fast Blue B turned green. The rest of the
channels produced negative results. Because the chips are printed with
colored wax, it was easy for the user to determine the result, by simply
comparing the developed color with that color printed on the device.
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Figure 3.22: A demonstration of the µPAD developed to detect seized
drugs: Top - Blank Sample; Bottom- a positive result for morphine.
Each lane of the device is labeled with the name and color at which
each analytes should appear Lane 1 ephedrine (Eph),
metamphetamine (MA) and MDMA; Lane 2 cocaine (Coc), codeine
(Cod), ketamine (Ket) and thebaine (The); Lane 3 codeine (Cod),
metamphetamine (MA), MDMA and morphine (Morp); Lane 4 ketamine
(Ket) and morphine (Morp); Lane 5 amphetamine (Amp); Lane 6
morphine (Morp) and MDMA.

D.

Storage and Stability

We have examined various methods to enable long-term storage of the
paper microfluidic chips. The first method was to save the paper chips in
plastic envelopes. After 3 months, only the Co(SCN)2/ NaOH - test and
modified Scott’s reagent remained effective. The other reagents did not
immediately react with drug solutions; however they did produce a color
change if they sat overnight. The second method was to seal the paper
chips within a nylon film pouch. Since Ninihydrin reagent – paper chips
changed color after heating during the sealing process, we heated the
laminar sheets surround the paper chips but did not heat areas where
reagents were spotted. The paper chips were kept in dark drawers and in
the refrigerator. All chips reacted with target drugs after one month. After
two months, all reagents produced the expected result in under 5 minutes
with the exception of the Fast-Blue and ninhydrin reagents. These two
reagents required an additional twenty-five minutes to produce a positive
reaction.
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5. Conclusions
Traditional screening tests using colorimetric reagents require a series of
individual tests to produce a positive result, potentially wasting precious
evidence and requiring time to manipulate samples and reagents. These
traditional tests result in LODs that are above 10 ug, and the total cost for
analysis is approximately 4 to 6 dollars per test. In this project, a rapid and
sensitive method using a paper microfluidic device has been developed as
an alternative to spot tests for the presumptive determination of a variety
of illicit seized drugs. The device, not much larger than a postage stamp,
produces observable color changes that are detectable by the naked-eye
that are sufficient to detect a few micrograms of each compound, in under
5 minutes. The procedure uses low quantities of reagents in an easily
stored format and demonstrates improved sensitivity when compared to
solution based colorimetric testing. The cost for manufacture is minimal,
approximately 20 cents per device. In addition, since the reagents are
absorbed onto the paper the procedure is much easier to perform and less
hazardous to use. The multichannel system permits the simultaneous
detection of compounds using a variety different reagents. This process
greatly increases the specificity of the method. The system also permits
the user to distinguish between illicit drugs, drug diluents and common
powders. Overall, we expect this procedure to greatly benefit forensic
testing, customs and other applications where quick portable testing of
unknown powders is necessary.
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Chapter 4. Gold nanoparticles/aptamers based paper microfluidic device
designed to cocaine detection
1. Introduction
A. Gold nanoparticles
For more than 40 years, new uses for gold nanoparticles (AuNPs) have
emerged within the fields of nanotechnology and nanoscience. Variation
in the size and shapes of these nanoparticles result in a wide variety of
chemical, electronic and optical properties that make them attractive for
applications in chemistry, biology, physics and engineering.
a. Preparation of Gold Nanoparticles
The synthesis of gold nanoparticles can be separated into homogeneous
and heterogeneous methods. Homogeneous methods involve AuIII
reduction in aqueous or organic media followed by surface stabilization to
minimize aggregation and precipitation. [1] Synthetic methods include
chemical, photochemical, electrochemical, sonochemical and microwaveassisted reduction methods. [1] Chemical reduction is a popular and easy
method, and this procedure is capable of producing a narrow size range of
nanoparticles. For example, the Brust-Schiffrin method utilizes an organic
phase and can produce 2-10 nm sized using NaBH4 as reductant and
organothiol as a surface protecting agent. [2] Alternatively, the Turkevich
method occurs in aqueous phase and produces 10-20 nm gold
nanoparticles using citrate both as a reductant and a surface protecting
agent. [3] Larger nanoparticles (10-50 nm) can be created
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using ascorbic acid and CTAB in the aqueous phase and particles with
sizes up to 200 nm have also been created. [4]
When nanoparticle synthesis uses a surface support, deposition-reduction
or reduction-deposition, can be used. [1] Each process has two steps.
The deposition-reduction method involves the deposition of AuIII
compounds onto the support, followed by reduction into metallic gold
nanoparticles under thermal treatment. [1] The reduction-deposition
method utilizes gold precursors followed by reduction with stabilizing
agents and deposition of the resultant gold colloids onto the support. The
deposition-reduction method is commonly used in the synthesis of small
particles while the reduction-deposition method can synthesize different
nanoparticle sizes depending on the different colloid preparations.
The method used in this project for the creation of gold nanoparticles
involved the use of a citrate reduction. The citrate method can synthesize
very stable gold nanoparticles with small sizes.

The chemical reaction to

produce the nanoparticles is shown below:
6Au3+ + C6H5O73- + 15OH- → 6Au + 6CO2 + 10H2O
In the synthesis, trisodium citrate simultaneously acts as a reducing and
stabilizing agent. The monodispersity and size of nanoparticles can be
controlled through the modification of reaction conditions. For example,
silver ions can adsorb to the surface of gold nanoparticles restricting the
ultimate size of gold nanoparticles. [5]
Once prepared, the surface of citrate-coated gold nanoparticles can be
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modified for use in biomedical applications. Citrate-capped spherical gold
nanoparticles provide a negatively charged citrate surface, that can either
bind to positive charges from proteins [6], react with cells via covalent
conjugates [7], or functionalize with synthetic oligonucleotides [8].
b. Chemical and physical properties of gold nanoparticles
Gold nanoparticles are classified into three types based on their size
range: clusters containing sizes less than 2 nm, catalytic particles with
sizes 2-10 nm, and plasmonic crystals with sizes from 10-300nm. [1] Gold
nanoparticles with diameters from 1-10 nm are described using the
‘monolayer protected cluster’(MPC) model, in which gold nanoparticles
couple with three layers, central atoms which contain the inner gold atoms
with a close-packed crystal structure, surface atoms which stay in outer
layers as the surface, and surface protecting organic ligands or
surfactants. [1,9] (Figure 4.1) The surface atoms have more activity than
the closed-packed atoms. [1]

Surface protecting organic layer
Surface atom layer
Central gold atom layer
Packed in a fcc structure

Figure 4.1. A structural model of a single gold nanoparticle. [1]
Shape is also an important parameter. Gold nanospheres are formed at

79

small sizes of 10 nm or less. As the size is increased, the particles can
also take shape as nanoshells and gold nanorods. [10] Nanoparticles can
be charge stabilized or sterically stabilized. Sterically stabilized gold
nanoparticles are usually prepared with long-chain or dendritic polymers
as the stabilizing agents. [11] These compounds produce steric
stabilization in which polymers surround the surface of gold nanoparticles
as layers. [9] (Figure 4.2) When the nanoparticles have zeta potentials
from 20m V to -20 mV, insufficient electrostatic stabilization results in
unstable nanoparticles; when the nanoparticles have sizes greater than 20
mV or less than ~ 20 mV of zeta potential, the particles have sufficient
electrostatic repulsion in solution and they are stable. [9]
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Figure 4.2 Stabilization mechanisms of monolayer nanoparticles: A.
electrostatic stabilization; B. Steric stabilization. [9]
The zeta potential of nanoparticles can be affected by their environment or
the presence of surface contaminants. High salt environments produce
aggregations that result from an overlap of double layers between gold
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nanoparticles. Alternatively, proteins and other biomolecules protect the
surface charge of the gold nanoparticles making aggregation less likely.
The chemical and physical properties of gold nanoparticles are dependent
on their size and shape. The optical reflectivity and the conductivity of the
metals depends on the movement of quasi-free electrons in the ground
state through the metallic crystaline structure. When the nanoparticle size
is smaller than 5 nm, the chemical/physical properties depend more on the
surface effects than on internal characteristics. When the nanoparticles
narrow to 10 nm or lower, their melting points, surface areas and
interatomic separation decrease, and the binding ability to other molecules
increases. Therefore, when nanoparticle sizes increase to 10-300 nm, the
particles have a strong interaction with light as a result of the localized
surface plasmon resonance (LSPR). [1,12]
c. Optical properties of gold nanoparticles
Gold nanoparticles have strong light absorption in the visible spectra
because of the surface plasmon resonance (SPR) effect.[13] The optical
properties of gold nanoparticles are determined by the resonance
wavelength, the extinction cross-section, and the ratio of scattering to
absorption on the nanoparticle dimensions.[9] Gold nanoparticles with a
diameter smaller than 2 nm do not produce surface plasmon resonance
because the plasmon bands almost completely quench in these
nanoparticles.[9] Gold nanoparticles of 2-100 nm exhibit surface plasmon
resonance (SPR) as the dominating optical feature and these

81

nanoparticles tend to produce a bright red color in colloidal form. When
the gold nanoparticles increase the size, the wavelength of the maximum
extinction shifts to longer wavelengths. These red shifts are also
associated with an increase in peak intensity. [14] Gold nanoparticles
larger than 2nm in size have an extinction cross-section with a light-toheat conversion at nearly 100% efficiency, high photostability, and the
ability to amplify electromagnetic fields near the metal surface. When gold
particles are smaller than 60 nm, they have a balance between scattering
and absorption. The particles have multipolar effects when the particle
size is bigger than 60nm. [1]
Gold nanoshells have better optical cross-sections than nanospheres with
the optical resonance occurring in the near-infrared region. In general,
increasing the size of gold nanospheres increases the resonance
wavelength. [10] Nanoshells also have a linear relationship between the
size and their total extinction, and gold nanorods produce optical crosssections with a smaller effective size. [1,10]
The size, polydispersity, and the shape of gold nanoparticles affects the
SPR wavelength. Particle aggregation also effects the SPR wavelength
and other optical properties. [13] For example, aggregation causes a redshift in the maximum absorption. Color changes that result from particle
aggregation have been used in many fields as a detection method. [1] The
DNA-functionalized gold nanoparticles are widely used because of the
color changes of red/blue of as the colorimetric indicator. [15,16]
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d. Functionalized gold nanoparticles
Gold nanoparticles can be modified through derivatization of the surface of
the gold monolayer. The addition of the surface functionalization involves
an extra step in the synthesis of gold nanoparticles or through later mixing
with other molecules. [1,9,17] The common functionalization methods
include PEGylation[18], peptide/amino acid conjugation[19],
oligonucleotide functionalization[20], and others[21]. Gold nanoparticles
can be easily modified depending on specific binding to thiol groups. The
physical and chemical properties of gold nanoparticles depend on the size
of gold nanoparticles. The modifications on gold nanoparticles change the
surface charges and the size as well as the physical and chemical
properties of the particles. [9]
Overall, the method of synthesis, the size, and the surface charge affect
the physical, chemical and optical properties of gold nanoparticles.
Modifications to the surface change the properties of gold nanoparticles
and increase their potential applications in biomedical fields. Gold
nanoparticles can produce a salt-induced aggregation and cause color
changes from red to blue. The salt based aggregation affects
functionalized gold nanoparticles much less than pure gold nanoparticles,
especially DNA-functionalized gold nanoparticles. This salt-induced effect
can be important in the bio-related applications in which a target is
determined based on a colorimetric reaction.
B. Aptamers
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Aptamers are defined as small single-stranded DNA or RNA
oligonucleotides which are able to bind target molecules with high
specificity and affinity.[22] They usually have sizes ranging from 20 to 60
nucleotides, and they can bind different types of target samples which
ranging from inorganic ions, small molecules such as pharmaceutical
compounds, large protein complexes and even entire cells. [22,23]
Aptamers are considered nucleotide analogues of antibodies, but their
preparation is much easier and less expensive. [24,25] The earliest
method for the production of aptamers was described by Tuerk and Gold
in 1990 who designed gp43 binding sequences. [26] Their procedure
became to be known as Systematic Evolution of Ligands by Exponential
Enrichment (SELEX). [27] A target molecule is used to select the most
specific sequences from a combinatorial nucleic acid library of random
oligonucleotides These sequences are then PCR amplified and the
process is until the most selective sequences are isolated. [27] The basic
steps of the SELEX process are shown in Figure 4.3. The beginning of a
SELEX process utilizes a pool of chemically synthesized random DNA or
RNA oligonucleotides with 1013 to 1015 sequence. These sequences are
incubated with the target. In the next step a binding complex is separated
from the unbound and weakly bound oligonucleotides. The target bound
oligonucleotides are removed and amplified by PCR (DNA SELEX) or
reverse transcription-PCR (RNA SELEX). The amplified sequences
added to a new oligonucleotide pool and another cycle of SELEX is

84

initiated. Several cycles of selection and amplification of the target
oligonucleotides produces an increase in the affinity and specificity of the
aptamer to the target. The number of cycles depends on the size and
number of binding sites on the target. When matched oligonucleotides are
cloned to create the aptamer clones, these aptamers are sequenced and
analyzed to determine their binding properties. Some aptamers may
require extra modifications to meet special requirements such as
heterogeneous surface binding. [27]

Nucleic acid library

Target

1st SELEX-round
Selected
oligonucleotides
library

Conditioning

SELEX Process
Partitioning

Amplification
- PCR
- RT-PCR

Cloning
Designed aptamers

Figure 4.3. In vitro selection of target-specific aptamers using SELEX
technology. [27] A synthetic random DNA library containing ~105
sequences is directly employed in the SELEX process for the selection of
DNA aptamers. Each cycle includes selection, amplification, and
conditioning. The target incubates in the library for binding, and the
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unbound sequences are washed out from the binding complex. The
target-bound oligonucleotides are then separated from the complex,
copied and amplified by PCR. The amplified oligonucleotides add to the
next DNA library, and a new cycle for the target happens again. Usually,
an oligonucleotide with high affinity and specificity is prepared after 6-20
cycles.
Aptamers are a useful alternative to antibodies because their preparation
is easier, more humane, and can be performed at a lower cost than
antibodies. Over the past ten years, the development of aptamers has
improved in terms of speed and selectivity. Many of these molecules are
applied as optical sensors through the incorporation of enzymes,
nanoparticles, quantum dots (QDs) and dyes. [22]
Aptamers have been successfully developed for the target molecules of
inorganic ions [28], small organic molecules [29], nucleotides and
derivatives [30], nucleic acids [31], peptides and proteins [27, 32] With
appropriate labeling or downstream processing, this binding step can be
used to indicate the presence of the target molecule in an unknown
sample. [ 33] The detection of drugs and their metabolites is a particularly
important applications in the use of aptamers. For example, a series of
different aptamers have been developed to detect the presence of
cocaine. Since the target is a small molecule of 303.353 g/mol, specificity
can be a difficult to achieve and the sequences utilized include ssDNA and
RNA based aptamers. The detection methods utilized for cocaine include
fluorescence [34,35], electrochemistry [36,37] and colorimetric probes.
Colorimetric methods can be separated into methods involving the
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monomeric dyes [38] and gold nanoparticles aggregation. [39,40]
In summary, aptamers offer high selectivity and affinity to the target with
easier preparation than current immunoassays. These oligonucleotide
based biosensors can compete with other matrix elements to detect the
target with minimal problems with interferences.
C. Lateral flow immunoassay
Many µPAD detection systems utilize the principle of lateral flow
immunoassay (LFIA). In LFIA, a liquid sample is deposited on the sample
pad and moves through the pad via capillary action. The analytes pass
different zones where they are designed to interact with and/or bind to
antibodies as well as gold nanoparticles. A LFIA device consists of
several parts: (1) sample application pad; (2) conjugate release pad; (3)
membrane; (4) test line and control line; (5) wicking-absorbent pad.
(Figure 4.4) A sample reacts with at least two lines located on the strips: a
test line and a control line. The test line captures and detects the complex
of antibodies/analyte producing a color change resulting from nanoparticle
aggregation while the control line detects unmodified analyte and/or
indicates a proper flow of the liquid through the strip. As the end of the
strip there is an absorbent pad which absorbs the excess solvent.[24]
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Application window

Reading window

Top View
Gold nanoparticles/ anti-antigen 2
conjugates

Test Control
Line Line

Sample (Antigen)
Antibody 1, Test zone

Sample Pad
Side View

Absorbent pad

Conjugate pad

Membrane

Antibody 2, Control zone

Figure 4.4 An example of a sandwich format of lateral flow immunoassay.
[41] Samples are deposited on the sample pad and then move through
capillary flow to the conjugated pad on membrane. When the AuNPs/antiantigen 2 was captured by antibodies, it produced a red line in the
antibody area.
The LFIAs are divided into two types of assays, competitive and sandwich.
The former detects analytes having a single epitope and low molecular
mass while the latter detects analytes with larger molecular weight
containing more than one epitope. [41] The sandwich mechanism is more
effective than the competitive assay. The sandwich assay has a test line
with one analyte-specific antibody, and a conjugate release pad containing
a second, labeled, anti-analyte antibody. The sample will bind during the
primary process to the first antibody which is coupled to a gold
nanoparticle. Then the sample-antibody conjugate is detected at the test
line through the interaction between the second epitope and can be
immobilized antibody at the test threshold. The response is directly
proportional to the amount of analyte in the sample.
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D. Gold nanoparticles/Aptamer based biosensors
Aptamers couple with enzymes, nanoparticles, QDs and dyes as the
biosensors. Although QDs were first adapted to aptamer detection
strategies by Levy and coworkers [42], gold nanoparticles become more
increasingly popular because their absorption and optical properties
change with the aggregation state. The color changes associated with the
aggregation (purple-blue) and disaggregation (red) are easily visible to the
naked eye without sophisticated instruments. In addition, gold
nanoparticles are more biocompatible, easier to bio-conjugate, and less
toxic than QDs. [1,9,34]
Gold nanoparticles will aggregate in the presence of added salt. However,
gold nanoparticles can functionalize with biomolecules, and these
functionalized nanoparticles can prevent the salt-induced aggregations
from a low-salt solution even to an isotonic solution of salts. [43]
Several groups have developed different aptamer/ gold nanoparticles
based biosensors. Most of published colorimetric methods utilizing
AuNPs/aptamer based detection of cocaine are used in solution. Li et al.
[44] modified a AuNPs/apatmer complex using biotin. In their device,
biotinylated gold nanoparticle/aptamer complexes were added to a
conjugation pad. Next cocaine was added. Upon reaching the conjugation
pad, the drug was trapped by the biotinylated AuNPs/ aptamer complex.
The results in release of nanoparticles, which continue to flow downstream
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where a streptativdin test line captures the nanoparticles producing a red
response.
In summary, gold nanoparticles can bind to aptamers with the result that
these complexes can avoid salt-indicated aggregation. As a result, the
DNA-functionalized gold nanoparticles maintain a red color in the
presence of salt. In addition, the gold nanoparticles will aggregate together
and produce a color change of blue in the presence of Mg salt solutions.
Thus, functionalized nanoparticles can be used in colorimetric detection
for target analytes.

2. Goals
The goal of the present project was to develop a paper-based microfluidic
device to detect seized cocaine using specific drug binding aptamers and
gold nanoparticles. The project included the determination of the
capability of gold nanoparticles to move and aggregate on paper chips as
well as characterizing the mobility and binding capability of anti-cocaine
aptamers. In addition studies were performed on the potential
modification of aptamers and gold nanoparticles for use in the detection of
cocaine on paper microfluidic devices.
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3. Chemicals and Methods
I.

Chemicals

Gold (III) chloride trihydrate (≥ 99.9%) was purchased from Sigma-Aldrich
(St Louis, MO). Sucrose, magnesium chloride hexahydrate and sodium
citrate dihydrate were purchased from Fisher Scientific (Fair Lawn, NJ).
The DNA sequences described by Fan et al.[40] were used to create the
aptamers ACA-1: ACAGCAGGGTGAAGTAACTTCTTG and ACA-2:
GGGAGTCAAGAAC, and the sequences were purchased from IDT
(Coralville, IA). Cocaine standards were purchased from Sigma (St Louis,
MO).
II.

Synthesis of AuNPs

The preparation of AuNPs followed the reported produce. [45] All
glasswares washed with aqua regia and d.i. water as well as the air drying
before the synthesis. 0.039 grams of tetrachloraurate (III) hydrate was
dissolved in 100 mL of d.i. water to 1 mM and 11.41 grams of sodium
citrate dehydrate was dissolved in 10 mL of d.i. water to 38.8 mM. The
solution of HAuCl4 was heated to the reflux under stirring, and then the
citrate solutions added to the reflux solution for another 10 minutes. After
the addition of citrate, the pale yellow of the gold solution turned colorless
and then black and finally wine-red in around 1 minute. The molar ratio of
Au: citrate kept 1:3.8 in the solution. After 10 minutes, the flask with
solutions sat in the ice bath for another 15 minutes. The AuNPs solution
transferred to the volumetric flask and kept the volume of 100 mL with d.i.
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water. The average particle size was determined by a dynamic light
scattering measurement (ZetaSizer Nano, Malvern, UK ).
III.

Designs of µPADs

Two single channel µPADs were designed to detect cocaine samples.
(Figure 4.5). The left design was used to detect the MDQ and the
interference tests, and the right one was the design for the presumptive
tests. Both designs have 2 zones A and B. Zone A was used to contain
the AuNPs and the area was also used for colorimetric detection; zone B
was the area used to deposit the aptamers. A second design (left hand
side) had a third region, zone C, which was used for the deposition of
sample solutions. A commercial wax printer (Xerox Color Cube 8750,
Xerox, US) was used to print the single channel design on
chromatography paper Whatman #1 (GE Healthcare, UK). The paper was
wrapped in aluminum foil and passed through a laminator at 160 °C, a
speed of 1.6 cm/sec (Tamercia Tashin Industrial Corp, TCC-6000) for 5
times. The laminator is used to melt the wax into the paper and create
hydrophobic barriers. Samples and reagents are next deposited in the
designed positions to optimize the color change on paper chips. Figure 5
showed the design of the device with letters indicating the potential
locations of each reagent and samples. A 2 μL of AuNPs dropped on
Position A and 3 μL of ACA-1 and ACA-2 were separately added to
Position B. All reagents were added to μPADs and then dried. Otherwise
the solution sample would spread along its corresponding channel. In the
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detection tests, 1 μL of cocaine liquid samples were placed on Position C.
In the reference tests, 1 μL of each sample was added to Position C. Vials
were prepared for use with the carrier solution. Each vial contained 300
μL of 2.8M MgCl2/ 0.15mM sucrose (v:v=1:1).

Figure 4.5. Left: The design of the AuNP/aptamer based μPAD used in
these experiments. Zone A: AuNPs area; Zone B: aptamer (ACAs) area;
Zone C: Sample area. Right: A presumptive test was developed for
cocaine detection using this device. The process involves dipping a
paper tab of the device into a solution containing the cocaine target. The
circled region (1) is the connecting channel between gold nanoparticle
area and aptamer area.
IV.

Estimation of Visual LOD and MDQ

A modified paper chip (Figure 4.5 Left) was used in the determination of
LOD. One μL of cocaine solution at a concentration from 1ng/mL to
10mg/mL was deposited onto the sample area (zone C - Figure 4.5,
Left). Sample tests were repeated 9 times. The visual LOD was based on
the color intensity at which greater than 90% of a group were able to
detect the difference between a positive sample and a blank. [47] The
camera-based LOD was performed using pictures recorded by a CCD
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Camera from AmScope Inc. (Irvine, CA) attached to a Zeiss microscope
(using a white background). The microscope was set at a magnification of
8x and a depth 1of 1.0 mm. The digital camera was set to an exposure
setting of 120, exposure time 509, and gain 1.20; Color temperature was
6503 and Tint 1000. Data analysis was performed by ImageJ software
1.50i. The color analysis was performed in the AuNPs area. (zone A Figure 4.5, Left) The camera based LOD was estimated as three times the
standard deviation plus the blank signal (3s+b) of the quantity of drug at
the inflection point for nanoparticle aggregation.
V.

Interference tests

Publix granulated sugar, Arm & Hammer baking soda, ionized salt, Publix
powdered sugar, King Arthur gluten free flour, Rumford aluminum-free
baking powder, foot powder, tablets of Excedrin and ibuprofen, were
purchased from supermarkets in Miami, FL. Procaine was purchased
from Acros Organics (Waltham, MA). Caffeine, amphetamine,
methamphetamine, ketamine, ephedrine were purchased from SigmaAldrich (St Louis, MO). Morphine and codeine were purchased from RBI
(Natick, MA). All samples were prepared as 1mg/mL solutions in water for
tests. Benzoylecgonine (1mg/mL) and ecognine methyl ester (0.1mg/mL)
were purchased from Cerilliant (Round Rock, TX). The modified device
(Figure 4.5, Left) was used in the interference tests. 1uL of each
interference solution was added to the sample area (zone C - Figure 4.5,
Left) and each test was repeated three times.
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4. Results and Discussion
I.

AuNPs/Aptamer detecting cocaine in solution tests

Two sets of cocaine aptamers were tested in the solution tests. [39,40]
Zhang et al. [40] developed a set of anti-Cocaine aptamers (ACA-1 and
ACA-2). This aptamer set included 2 unmodified DNA sequences, ACA-1
with 24 bases and ACA-2 with 13 bases. The mixture of ACAs and gold
nanoparticles produced a color change from red to blue in the presence of
cocaine and NaCl, but did not change with NaCl in the absence of
cocaine. Alternatively, Liu et al. [39] developed three sequences for
cocaine detection. According to their paper, the aggregated nanoparticles
denature upon addition of cocaine and external heating, producing a color
change from blue to red. We examined this process and were able to
successfully incubate the gold nanoparticles with the aptamers, but the
decomposition of the aptamer/gold nanoparticles did not occur on
efficiently. Therefore, we reexamined the use of Zhang’s ACA aptamers.
The advantage of this set of aptamers was their sensitive to the presence
of cocaine (as low as 2 μM [40]) and their quick reaction in solution tests.
In addition, these aptamers were unmodified and less expensive to
produce than those requiring biotin or thiol functional groups. The
detection mechanism for the paper device was based on the capability of
the free aptamers to bind cocaine or the surface of the gold nanoparticles.
This binding process was thermodynamically favored and did not require
external energy. In comparison, the aptamers created by Liu et al. [39],
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could not be used in homogeneous assays as they required heating to
separate the aptamers from the gold nanoparticles prior to binding
cocaine, making the tests difficult to operate.
Picture 4.6 shows the production of color changes involving the change
from a red-wine color to the purple color in the presence of cocaine.

Figure 4.6. AuNPs/Aptamer based solution test for cocaine samples. In
the absence of cocaine, the two ACA aptamers bind to the surface of gold
nanoparticles and the complex does not aggregate with NaCl. The
resultant mixture produces a red color. In the presence of cocaine, ACA
aptamers bind to cocaine molecules and the gold nanoparticles aggregate
producing a purple color. Left: Blank sample test; Right: cocaine sample
test.
II.

AuNPs on μPADs

The original μPADs design for cocaine detection was determined by
changes in mobility causing aggregation of AuNPs on paper chips. Other
applications of AuNPs on μPADs only used μPADs as a platform for
detection [48,49], however, we have designed our system as a ready-touse detector. The system permits sample analysis and detection based on
capillary flow along a hydrophilic channel to the designed position where
salt-induced self-aggregation and color development occurs.
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a)

Preparation of AuNPs on μPADs

A number of procedures were used in preparing the μPADs for analysis.
These included immersion and deposition procedures. In the immersion
method, the entire chromatographic paper was placed in a AuNP solution
in which concentrations ranged from 1 mM to 0 mM for times ranging from
1 to 24 hours. When the immersion period was less than 12 hours, the
AuNPs did not attach to the paper and the color of paper was pale pink to
colorless. When the time was increased to 24 hours, the AuNPs appeared
on chromatographic paper as a red color. The intensity of the color varied
with concentration. Nanoparticles at a concentration from 0.5 mM to 0.6
mM, appeared dark red. Unfortunately, when AuNPs at concentrations of
0.5 mM or higher were used the color changed to purple-red or black
when the paper dried, while AuNPs of 0.4 mM or lower appeared colorless
on paper. Therefore, the immersion method can be used in the
aggregation of AuNPs on paper for other purposes, but it was not
appropriate for use the colorimetric detection.

97

0 mM
0.6 mM
0.7 mM
0.8 mM
0.9 mM
1 mM
Wet

Dried

Picture 4.7. Effects of different concentration of AuNPs on
chromatographic paper based on an immersion method. Gold
nanoparticles were stable at concentrations below 0.6 mM in immersion
methods on paper chips.
An alternate method for application to the paper was the deposition
method. A zone was created on the paper with an inner diameter of
3.5mm (Figure 4.5) and 2 µL of a solution containing 1 mM, 0.5 mM, and
0.25 mM of AuNPs were tested in this area. The resulting color produced
on the paper was a pink-red color with the 1mM solution while the 0.5 mM
and 0.25 mM solutions produced a paler color which was hard to see.
Therefore, 1 mM was the preferred concentration for the colorimetric
detector.
When the synthesized AuNPs contained ~15% AuNPs of 15nm, the
deposition of AuNPs appeared as red color on the AuNPs area but also
produced a darker red or purple-red in the connecting areas. Depending
on the distance between the point of application and the paper, sometimes
the red color was darker in the external areas when compared to the
middle of the deposition area. It was assumed that the darker spots on
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the paper were due to the aggregation of the larger sizes of AuNPs.
To examine the effect of different quantities of AuNPs on paper, different
volumes of 1mM AuNPs (2 µL, 4 µL, 6 µL, 2 µL *2 times, 2 µL*3 times)
were added to the same position. When the volume of a single drop was
higher than 2 µL, the AuNPs spread to the connecting channels and this
region turned black. When multiple applications of small quantities of
nanoparticles were added, the spreading effects decreased but the
aggregation of the AuNPs in the designed positon increased and the area
turned to purple-black. Therefore, a single deposition of 2 µL AuNPs of 1
mM was defined as the best method to optimize color effects on
chromatographic paper.

b. Mobility of AuNPs on µPADs
In the original design, the AuNPs were expected to move to the end of the
channel with the capillary flow. Unfortunately, the AuNPs did not move
with the either water or sucrose on unmodified chromatographic paper.
The AuNPs also aggregated on the micropads containing sucrose and
water without any salt. (Figure 4.8)
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Figure 4.8. Effects of AuNPs paper without PVA/Tween 20 Treatments.

Therefore, it was necessary to perform surface modifications to the paper
devices in order to increase the mobility and decrease the aggregation of
AuNPs. Previous results using lateral flow devices [39] have indicated
that AuNPs can move through membranes following the addition of
sucrose. Surfactants such as Tween 20 and Tween 80, as well as the
polymer poly(vinyl alcohol) (PVA) were also added to the paper to
examine their effect on the mobility and aggregation of the nanoparticles.
The modified paper was then immersed in the gold nanoparticles solutions
for 24 hours. Tween 80 did not decrease the aggregation of AuNPs which
turned to purple; Tween 20 decreased but did not eliminate the
aggregation of AuNPs which turned to darker red while PVA minimized the
aggregations yielding a pink-red color. Solutions of PVA from 0.01% to
1% provided the same color effects. However, AuNPs on PVA treated
paper were too stable, these AuNPs did not move with capillary flow with
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using sucrose solutions or distilled water.
To optimize the mobility and the stability of AuNPs on treated paper, we
next examined mixtures of 0.01% PVA and 1% Tween 20 with different
ratios (1:1, 1:9, 1:99). All treatments stabilized the AuNPs on paper,
producing a red color. As the quantity of AuNPs on the paper increased,
the darkness of the red color increased. To optimize the movement of the
AuNPs, we examined different quantities of AuNPs at different ratios of
PVA/Tween 20 and sucrose. The spotting positions are illustrated in
Figure 4.9-top. With 0.15mM sucrose, the only successful condition was
1% Tween20/ 0.01% PVA (v:v=99:1) spotted in location 1 with AuNPs.
As shown in Figure 4.9-a, we could observe color

Table 4.1. Effects of surfactant/ polymers modified AuNPs paper. PVA
inhibited the aggregation of gold nanoparticles on paper, Tween 20
inhibited most of the aggregations of nanoparticles, Tween 80 does not
inhibit nanoparticle aggregation.
AuNPs/ PVA

AuNPs/ Tween 20

AuNPs/ Tween 80

No Aggregation

Some
Aggregation

Some
Aggregation

Deposited Water

No Aggregation

No Aggregation

Aggregation

Deposited
5M NaCl

No Aggregation

Some
Aggregation

Aggregation

Deposited 0.15mM
Sucrose/5M NaCl

No Aggregation

Some
Aggregation

Aggregation

Wet -> Dried
Phenomena
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movements from position 1 (lower ball) to position 2 (top ball) with a
solution containing 40mg/mL of sucrose, 50%Tween 20, and 1%PVA.
More AuNPs moved to the end of the channel when the paper chips were
treated with 50-30% Tween 20 mixed 1-0.1% PVA. (Figure 4.9-b) To
optimize the movement of AuNPs, we tried different ratios of AuNPs to the
PVA/Tween 20 along with 50 mg/mL sucrose. When the ratio of AuNPs:
PVA/Tween 20 (v:v) was above 4:1, the moving distance and the darkness
of the red color were obvious to the naked eye. (Figure 4.9) The whole
procedure took around 10 minutes.

PVA/Tween 20

1

AuNPs

Sucrose

!

!
!!!!!!!!!!!!!!!!!!!!!!!!!!Left!!!!!!!!!!!!!!!Right!!!!(a)!!!!!!!!!!!!!!!(b)!!!!!!!!!!!!!!(c)!
!

Figure 4.9. Effects of surface treatments on paper for AuNPs. Bottom:
Left: AuNPs paper before test; Right: (a) 50mg/mL sucrose with the 1%
Tween 20: 0.01% PVA in location 1; and (b): 40mg/mL sucrose with the
50% Tween 20: 0.01% PVA in location 1.
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There were several problems when examining the mobility of the AuNPs
on µPADs. The biggest issue was the low reproducibility of the moving
AuNPs. We controlled all conditions in the preparations and operations,
however, the same batch of AuNPs often produced different results. A
larger quantity of AuNPs on the paper was required to achieve movement
of AuNPs, but this process produced colors from red to purple in the
designed position. If the width of the moving channel was reduced, the
time increased to 1 hour and most AuNPs aggregated in the middle of the
channel. If the moving channel was wider, the AuNPs moved past the wax
barrier. Therefore, the design of this µPAD had to be changed.
c. Aggregations of AuNPs on µPADs
In earlier work, we found that a single deposition of 2 µL AuNPs of 1 mM
produced a red color on chromatographic paper. Also as noted, AuNPs
aggregate in solutions with the presence of salts. [1] Thus further testing
was performed on the ability of different concentrations of AuNPs to
produce aggregation. Table 4.2 shows that a concentration of 1 mM can
produce complete aggregation in the presence of salts and sugars.
Decreasing the concentration of gold nanoparticles reduced the
aggregation effects. Sodium chloride and magnesium chloride were
examined in both solution and on µPADs to examine their effect on
aggregation. Magnesium chloride produced a more intense color of
AuNPs aggregation in both tests. Therefore, magnesium chloride was
used as the aggregating agent in the moving solution. Sucrose did not
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cause aggregation in solution, however, gold nanoparticles did aggregate
on the µPADs as a result of the capillary flow of sucrose into their zone.
After tests of the mobility and aggregation, we utilized the aggregation of
AuNPs on µPADs instead of their mobility on µPADs as the colorimetric
detector. The next step was to determine if aptamers could bind AuNPs
on µPADs.

Table 4.2. Aggregation effects of AuNPs on µPADs. The color in the
table indicated the color change happened on µPADs. Black = Full
aggregations, Purple = Partly aggregations, Brown-red = little
aggregations, Red = No aggregations.
!

Type!

AuNPs!#1!

AuNPs!#2!

AuNPs!#3!

1mM!

0.5mM!

0.25mM!

Sucrose!

!

!

!

MgCl2!

!

!

!

NaCl!

!

!

!

!

!

!

!

!

!

AuNPs!concentrations!

w/out!
Surface!
treatment!

Sucrose!+!
MgCl2!
Sucrose!+!
NaCl!

!
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III.

Aptamers on μPADs

In our design, aptamers have two functions, (1) binding to gold
nanoparticles to avoid aggregation in the presence of salts; (2) binding to
cocaine. Gold aptamers should have sufficient mobility in the carrier
solutions to permit moving through the channel via capillary action, and
the ability to bind to the cocaine molecules.
Aptamers are colorless in solution so we needed a visual detection
procedure for µPADs tests. To do this we used SYBR Gold and SYBR
Green fluorescent DNA labeling dyes to track the presence
and movements of aptamers on paper chips. 2uL of dye and the ACAs
aptamer were separately dropped to the bottom-ball position on paper
chips. (Figure 4.10) Sucrose can move the aptamers through the
membrane, and the higher concentrations of sucrose can move even more
aptamers on a solid matrix. [39] A series of sucrose with different
concentrations were examined. 0.15mM of sucrose moved aptamers with
a highest speed. When the paper dried, these paper chips were put in
50mg/mL of sucrose solution until the moving solution arrived at the end of
the channel. A molecular imaging software of KODAK MI and a Gel Logic
100 were used to record the fluorescence of aptamers on paper chips.
The detected fluorescence indicated the positions of the aptamers after
the tests. Figure 4.10 showed that the dyes stayed in the bottom ball in
the blank test, but the dyes moved up to the end of the channel in the
presence of the aptamers. The moving fluorescence position
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demonstrated that the aptamers can move through the channel on µPADs
with sucrose. There was fluorescence in the middle of channel, indicating
that the optimized conditions for the mobility of the aptamer should be
either include a longer time for capillary action, or a shorter channel to
transform more aptamers.

(a)$$$$$$ (b)$$$$$$ (c)$$

(d)

Figure 4.10. Movements of Dyes and Dye/Aptamer on paper chips with
50mg/mL of sucrose. Left: SYBR Gold only; Mid-left: SYBR Gold-ACA-1;
Mid-right: SYBR+ACA-2; Right: SYBR Gold ACA1&ACA2.
The paper chips were next used to observe the binding of the ACAs
aptamers with cocaine in Figure 4.11. SYBR Green 5x was used as the
tracking dye. 4 uLof SYBR Green mixed ACA-1 and ACA-2 was
deposited at the bottom ball. 1mg of Cocaine was dissolved in 40mg/mL
sucrose. The bottom of the paper chip was placed in the sucrose solution
for 10 minutes and the fluorescent response was photographed in each
the channels as shown in Figure 4.6. The single aptamers or cocaine did
not produce fluorescence with SYBR Green. The application of a mixture
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of the two ACAs produced a fluorescence signal and the mixture of
ACAs/cocaine enhanced the intensity of the fluorescence. ImageJ
software was used to analyze the optical density of the top channels from
Figure 4.11, and the average optical density of ACA mixture/SYBR Green
was 0.005367, and the average optical density of ACA/SYBR Green/
Cocaine was 0.005521. The intensities indicated that ACAs can move
through the channel of µPADs and they can also bind cocaine on µPADs.

Figure 4.11: Results of SYBR Green with cocaine, ACAs and their
mixtures.
1. Only SYBR Green 5X;
2. SYBR Green 5X + Cocaine, 1mmol
3. SYBR Green 5X + ACA-1, 1mmol;
4. SYBR Green 5X + ACA-1, 1mmol + Cocaine, 1mmol;
5. SYBR Green 5X + ACA-2, 1mmol;
6. SYBR Green 5X + ACA-2, 1mmol + Cocaine, 1mmol;
7. SYBR Green 5X + ACA-mixture, 0.5mmol of each ACA; ACA
mixture/SYBR Green produced a fluorescence.
8. SYBR Green 5X + ACA-mixture, 0.5mmol of each ACA + Cocaine,
1mmol. ACAs/ SYBR Green/ Cocaine produced a brighter fluorescence in
the end of channel.
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IV.

Aptamers/AuNPs complex on µPADs

a)

Designs

The next step was to modify the aptamer/AuNPs assay to permit the
usage in μPADs as demonstrated in Scheme 1 (Figure 4.12). A series of
experiments were performed examining the stability and mobility of the
various components of the detection scheme. Initial tests indicated that
the gold nanoparticles bound strongly to the paper matrix. Thus, these
were placed at the end of the channel. Aptamers were placed in a zone
upstream of the AuNPs area. When the samples moved with the carrier
solution, the ACAs bind to the targets and then the complex of
aptamers/cocaine move toward the AuNPs area. Without the protection of
the free aptamers, the AuNPs would aggregate under due to salt-induced
aggregation. When the sample was not cocaine, the ACAs move with
carrier solution and bind to the surface of the AuNPs eliminating the
possibility of aggregation.
A series of experiments were next performed to test the stability and
mobility of the various components of the detection scheme. The results
were shown in Table 4.3. In the absence of aptamers, AuNPs on the
μPADs produced a color change with the capillary flow of water, sucrose
or sucrose/MgCl2. In the presence of aptamers, the red color of AuNPs
changed to purple when water was introduced. When the aqueous
solution included sucrose, the red color turned to a darker red. With an
aqueous solution containing sucrose and MgCl2, the color changed to red-
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purple. The next step was to optimize the concentration of the solution to
produce an intense color change.
b) Moving solutions
The components of carrier solutions were important, as these contain the
salt which produces the aggregation of AuNPs, and the sucrose which
assists the movement of the AuNPs, and increases the binding of
aptamers to AuNPs surfaces. A range of concentrations of salt and
sucrose were examined. The best results occurred with a MgCl2
concentration of 2.8m and 50mg/mL sucrose. Higher concentrations of
sucrose reduced capillary flow while lower amounts of MgCl2 did not
produce full aggregation. These results suggested that the sucrose in the
system helped to mobilize the aptamers towards the end of the channel
[39], and that the MgCl2 acted as the aggregating agent of the AuNPs.
The optimized sucrose/MgCl2 resulted in a salt-induced aggregation in the
presence of cocaine. The aggregation was inhibited in the absence of
AuNPs

Aptamer

Moving Solution

cocaine,
Table
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Figure 4.12. Schematic of the detection
of cocaine using AuNPs with aptamers.
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c) AuNPs/Aptamers on μPADs
The visibility of the color change on the μPADs depended on the quantity of
AuNPs and the method of addition. Lower concentrations of nanoparticles were
difficult to detect once the colloidal gold solution dried on the paper. 2uL of 1 mM
AuNPs deposited on the paper device with a size ranging 20 - 40nm produced a
pink-red color on the μPADs visible to the naked eyes. The color changes that
occured when AuNPs were used on μPADs in the absence of cocaine depended
on the quantity of the two aptamers on the paper. AuNPs are sensitive to salts
and produce salt-induced aggregation with the carrier solution of MgCl2 if
aptamers are not present. When present, the aptamers flow down the chip with
the capillary flow of the MgCl2/sucrose solution. When the aptamers arrive at the
AuNPs area, they inhibit aggregation even in the presence of the salt solution.
Figure 4.13 demonstrates that a linear relationship exists between the quantity of
the two aptamers and the red colored response on the paper (red component of
the RGB.) When the total amount of the two aptamers was less than 1.2 nmol,
the deposited AuNPs turned to gray indicating that the quantity of the two
aptamers was insufficient to bind to the surface of AuNPs and avoid aggregation.
When the aptamer quantity was 1.2 nmol or more, the aggregation of AuNPs
decreased and the color changed only from purple-red to light purple. At 8 nmol
or higher, AuNPs area remained red, indicating that a sufficient quantity of
aptamer was present to bind to the 2nmol AuNPs. This was judged to be the
optimal amount of aptamer. (Figure 4.13)
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At higher concentrations, a loss of sensitivity occurred. The binding effects
between AuNPs and aptamers for solution tests required a 1:1 molar ratio. On
paper however, a larger amount of aptamer was required to avoid the saltinduced aggregation. The color change of purple-red was hard to observe. The
expected color was purple-black or black as an indicator for the presence of
cocaine. The optimized amount was 1.2 nmol of ACAs which achieved the best
sensitivity.

Figure 4.13. The effect of increasing quantities of the two aptamers applied to 2
nmol of the AuNPs on paper. As the concentration increases a red color
appears. The optimum amount was 1.2 nmol of the aptamer mixture as this
amount achieves the best sensitivity.

Figure 4.14. The color change produced when the sucrose/MgCl2 solvent front
mixes with 2nmol AuNPs in the presence of differing amount of Aptamers on the
μPAD. A linear response is obtained as y=-0.004 – 0.01x, R2=-0.98. Error bars
represent standard deviations of triplicate measurements.[46]
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b) AuNPs/Aptamer based uPADs detecting cocaine
In these experiments a range of different designs were applied in the detection of
cocaine. The channel design (length and width) affects run time and can affect
the binding of cocaine/ACAs and the aggregation of AuNPs with salt. In the
current design (Figure 4.5), the dimensions are 4mm (length) * 2mm (width) in
the circled positions. These dimensions permit the carrier solution to move the
samples through the chip within 5 minutes, and provide a visual LOD of 2.5 μg
and an instrumental LOD of 2.4 µg. However, if this area is increased to 6mm (L)
* 1mm (W), the visual LOD drops, however, the run time increases to 30 minutes
or more

Figure 4.15. Example of the application of the μPAD in the detection of cocaine
HCl. Left: 5mg/mL cocaine sample. Right: Blank sample.
In a typical experimental test, AuNPs (2nmol) and aptamers (ACA-1 and ACA-2,
0.6nmol each) were prepared and added to the μPADs. In the presence of 10μg
cocaine, a solution of 2.8M MgCl2/ 50mg/mL sucrose moved through the aptamer
zone to the next location containing the AuNPs. Once this solution reached this
region, the AuNPs turned from pink-red to gray in 5 minutes. In contrast, in the
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absence of cocaine, the moving solution arrived at the end of the channel, and
the AuNPs area remained red. (Figure 4.15) All color changes were apparent to
the naked eye. The color changes of AuNPs indicated that aptamers could form
a tertiary structure around the cocaine not only in the solution but also on the
μPADs. Furthermore, AuNPs can produce a salt-induced aggregation on μPADs
and aptamers can stabilize AuNPs against the aggregation on μPADs. (Figure
4.13) Experiments were next performed to define the optimized conditions for
stabilization of the AuNPs and Aptamers on μPADs, while still permitting a
sensitive and robust method to detect the presence of cocaine.

c) Estimation of visual LOD and MDQ
Figure 4.15 illustrates that the relationship between the response of the red
component and the quantity of cocaine detected. When the cocaine amount was
0.1μg or lower, the AuNPs had a red/red-purple color. At amounts of cocaine of
0.5μg or higher a purple color change occurred and at 2.5μg or higher, the color
became grey-purple. The visual LOD was based on the color intensity at which
greater than 90% of a group of 13 individuals was able to detect the difference
between a positive sample and a blank. The camera-based LOD was calculated
at the inflection point for plot of red absorbance vs cocaine concentration. As is
illustrated by the figure, at 1.7+/- 0.2 ug of cocaine a rapid transition occurs due
the cocaine induced aggregation of the nanoparticles. This point was used to
determine a camera-based LOD of 2.36 µg (3s+b). The LOD was consistent
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over a range of 0.6 to 3.6nmol of each aptamer and 2 to 4 nmol AuNPs on the
μPADs.
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Figure 4.16. The effect of increasing quantity of cocaine on the response of red
component (RGB) from image J. As seen in the figure, at a signal intensity of
139, an inflection point occurs. This point is used to estimate the camera based
LOD of 2.36. The standard deviation of the estimate at the inflection point was
0.20 ug. The visual LOD was estimated based on a signal sufficient for 90% of
subjects to detect the color change and was 2.5 ug of cocaine.
Table 4.4. Estimation of instrumental LOD and visual LOD.
Drug

Instrumental LOD

Visual LOD

Cocaine

2.36 μg

2.5μg

b) Interference tests
Common white powders including baking soda, salt, powder sugar, flour, baking
powder, foot powder, Excedrin and ibuprofen were tested as potential
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interferences. All tested interferences maintained an intense red color indicating
a negative result. Common diluents used in illicit samples,

Table 4.5. Interference tests. All listed interference materials produced negative
results of red colors
Interference
Compounds

Types

Amount (ug)

Results

Benzoylecgonine

Metabolite

1.5

No Aggregation

Ecgonine methyl
ester

Metabolite

0.15

No Aggregation

Ketamine

Drug

1.5

No Aggregation

Codeine

Drug

1.5

No Aggregation

Morphine

Drug

1.5

No Aggregation

Ephedrine

Drug

1.5

No Aggregation

Amphetamine

Drug

1.5

No Aggregation

Methamphetamine

Drug

1.5

No Aggregation

JWH-073

Drug

1.5

No Aggregation

Caffeine

Adulterant

1.5

No Aggregation

Procaine HCl

Adulterant

1.5

No Aggregation

Sugar

Diluent

1.5

No Aggregation

Sucrose

Diluent

1.5

No Aggregation

Inositol

Diluent

1.5

No Aggregation

Excedrine

Common powder

1.5

No Aggregation

Ibuprofen

Common powder

1.5

No Aggregation

Foot powder

Common powder

1.5

No Aggregation

Baking soda

Common powder

1.5

No Aggregation

Sea Salts

Common powder

1.5

No Aggregation

Flour

Common powder

1.5

No Aggregation

Powder sugar

Common powder

1.5

No Aggregation

such as sugar, procaine, caffeine and inositol also produced a negative result.
Illicit drugs such as ephedrine, codeine, ketamine, amphetamine, morphine, and
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JWH-073 did not produce a color change; methamphetamine produced a
reddish-purple color. Metabolites of cocaine, benzoylecgonine and ecgonine
methyl ester were also negative. (Table 4.5)

5. Conclusions
A rapid and specific method using an AuNPs/aptamer based paper microfluidic
device has been developed for the field tests of seized cocaine. The stamp-size
paper device produces a detectable color change by the naked-eye or camera.
The method can detect microgram levels of cocaine in under 5 minutes. The
procedure uses environmentally friendly reagents in a flexible format. Compared
to current colorimetric testing procedures, the newly developed μPADs are
inexpensive and easy to use. When tested against a wide variety of potential
interferences, the μPAD has shown a high specificity and sensitivity.
Furthermore, this strategy has the potential to detect other illicit drugs as new
aptamers are developed. Overall, we believe this general procedure can benefit
the forensic detection of many types of illicit drugs.
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Chapter 5. Conclusions and Future Work
1. Conclusions
In forensic analysis, presumptive tests for drugs of abuse may be performed onsite or in a laboratory setting. With increasing laboratory backlogs, on-site and
point-of-care based testing have become important ways to prescreen samples
as well as to provide probable cause that a crime has taken place. The
colorimetric response from this type of presumptive test depends on the
sensitivity of the test and the sample type. Colorimetric tests are typically used
for seized drugs, while antibody-based, lateral flow immunoassay techniques are
used for trace detection of drugs in toxicological samples such as saliva, sweat
and urine. Although these methods are cheap and easy to use, they generally
lack multiplex capabilities, thus several individual tests are required to determine
the range of potential analytes. Since these procedures are presumptive, false
positive results can occur due to lack of specificity, and false negative results can
occur due to environmental interferences.
This project was designed to improve the specificity and sensitivity of screening
tests through the development of paper-based microfluidic devices for drug
detection. These tests will be cheap, simple to use, and will provide rapid
response times. Two different paper-based devices have been developed. The
first device was based on adapting current colorimetric tests to a paper based
format. Analytes included classes of seized drug samples such as opiates,
phenethyl amines, amphetamines and cocaines. The second type of device was
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developed for on-site detection of cocaine with aptamer based lateral flow assays
designed to utilize gold-nanoparticle coupled reagents.
The construction of the paper-based microfluidic devices was relatively simple
and only required chromatographic paper, wax-ink and a laminator. Wax ink
provides a hydrophobic barrier and the paper substrate creates hydrophilic
channels. This device utilizes capillary action to move the solvents, reagents and
drugs to the designed position, where previously deposited sample reagents
produce a color change, indicating a positive result. An advantage of the paper
based approach is that multiple channels can be designed to simultaneously
detect the presence of different analytes in a mixture.

(1) Colorimetric reagents based uPADs
Standard colorimetric reagents used in drug testing were modified for use with
paper chips.

These reagents are generally based on the detection of certain

functional groups and commonly involve interaction with transition metals. We
have developed a modified set of colorimetric reagents for the presumptive
detection of seized drugs to permit their use with paper microfluidic devices.
Reagents are placed in series along the length of each channel to permit
reactions to occur at set locations and times. The result is a safe and easy to
store device that permits detection of a wide variety of controlled substances and
just slightly bigger than the size of a postage stamp. The multiplex test can be
read in under 5 minutes and is stable for up to 3 months. The paper microfluidic
tests are inexpensive and simple to operate.
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(2) Gold nanoparticles/aptamers
Aptamers are alternatives to the lateral flow immunoassays that are currently
used. Aptamers have the capability to bind specific target molecules, they have
high selectivity and affinity. The change between dispersion and aggregation of
gold nanoparticles produces a color change from red to blue. The color appears
when hybridized DNA coupled nanoparticles are released from the aptamers,
following the binding of the aptamer to a target drug. A rapid and specific
method using a AuNPs/aptamers within a paper microfludic device has been
developed for the field testing of seized cocaine. The stamp-size paper device
produces a detectable color change by the naked eye or camera and can detect
microgram levels of cocaine in under 5 minutes. The procedure was found to be
selective against a wide variety of potential interferences. Furthermore, this
strategy has the potential to detect other illicit drugs as new aptamers are being
developed.
2. Future Work
The current work provides proof of concept for paper microfluidic devices as
useful platforms for seized drug determination. Prior to implementation, a more
extensive the validation of the current paper microfluidic devices would be
necessary before implementation in laboratory operations. This would include
testing of a wide range of drug substances and interferences. In addition, round
robin tests of reproducibility and sensitivity as well as determinations of false
positive/false negative rates should be undertaken. The effect of variations in
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reagent concentration and accuracy should also be performed. It is important to
note that for the multichannel device, most of the reactions have previously been
well characterized in terms of sensitivity and specificity for many years. [1,2]
Aptamer tests are relatively new, but there is a great body of literature on their
application. [3]
Future studies for drug analysis may also involve new color tests and channels
for other dangerous drugs such as cathiones and cannabinoids can be
developed. Lastly, aptamers designed for the determination methamphetamine
and codeine have been published. Initial laboratory studies have demonstrated
that the approach used for the determination of cocaine will also work in
methamphetamine and codeine determination. Thus this general procedure
should prove useful for a wide range of analytes so long as similar aptamer
based binding mechanisms can be developed.
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APPENDIX I
Table 4.5 The original records of the interferences tests.
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APPENDIX II
Calculation of the cost of paper microfluidic devices in this project.
a. AuNPs/Aptamers based paper chips
For each chip: 10 cents
- Aptamer = $ 0.07548 (ACA-1, $22.10/umole, $40.80/umole)
$ 62.9/umole * 1.2 nmole = $ 0.07548
Total $ 0.07548/chip
- AuNPs
HAuCl4, $56.982/g * 0.039g/100mL * 2uL = $ 0.00004445
Sodium citrate, $ 0.039/g*11.41g/100mLl*2Ul = $ 0.0000088
Total $ 0.000053/chip
- Chromatographic Paper & Wax ink = $ 0.00923 (1cm * 2cm)
$ 0.6595/ A4 size chromatographic paper, each A4 size paper can
prepare 72 chips, each chip = $ 0.00915
Xerox, ColorQube 8570 Black solid ink, $154.99/ 4 packs,
each pack $38.7475, each ink pack yields approximately 8600 pages
from their website data,we assume each pack prints 8000 pages, each page cost
$ 0.00484, each page prepare 72 chips, each chip will cost $0.000067 for ink
Total $ 0.0092
- MgCl2 = $ 0.0025
$0.1822/ gram * 5.6M * 150 µL = $ 0.00250
- Sucrose = $ 0.0005
$ 0.03122/ gram * 100mg/mL * 150µL = $ 0.0004683
Above all, the total cost is = $ 0.0877
b. Colorimetric reagent based paper chips
For each chip: 10 cents
Chromatographic Paper & Wax ink = $ 0.00923 (1cm * 2cm)
All chemicals using in the test costs less 10 cents.
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* Cut-off concentration * 50 uL
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